<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:59:10Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4671959" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:4671959</identifier><datestamp>2015-12-23</datestamp><setSpec>elsevierwt</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Cell</journal-id>
      <journal-id journal-id-type="iso-abbrev">Cell</journal-id>
      <journal-title-group>
        <journal-title>Cell</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0092-8674</issn>
      <issn pub-type="epub">1097-4172</issn>
      <publisher>
        <publisher-name>Cell Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4671959</article-id>
      <article-id pub-id-type="pmcid">PMC4671959</article-id>
      <article-id pub-id-type="pmc-uid">4671959</article-id>
      <article-id pub-id-type="pmid">26638071</article-id>
      <article-id pub-id-type="publisher-id">S0092-8674(15)01485-3</article-id>
      <article-id pub-id-type="doi">10.1016/j.cell.2015.11.005</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Redox Signaling by the RNA Polymerase III TFIIB-Related Factor Brf2</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Gouge</surname>
            <given-names>Jerome</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="fn1" ref-type="fn">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Satia</surname>
            <given-names>Karishma</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="fn1" ref-type="fn">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Guthertz</surname>
            <given-names>Nicolas</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Widya</surname>
            <given-names>Marcella</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Thompson</surname>
            <given-names>AndrewÂ James</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cousin</surname>
            <given-names>Pascal</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dergai</surname>
            <given-names>Oleksandr</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hernandez</surname>
            <given-names>Nouria</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vannini</surname>
            <given-names>Alessandro</given-names>
          </name>
          <email>alessandro.vannini@icr.ac.uk</email>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="cor1" ref-type="corresp">â</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Division of Structural Biology, The Institute of Cancer Research, London SW7 3RP, UK</aff>
      <aff id="aff2"><label>2</label>Center for Integrative Genomics, Faculty of Biology and Medicine, University of Lausanne, 1015 Lausanne, Switzerland</aff>
      <author-notes>
        <corresp id="cor1"><label>â</label>Corresponding author <email>alessandro.vannini@icr.ac.uk</email></corresp>
        <fn id="fn1">
          <label>3</label>
          <p>Co-first author</p>
        </fn>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>03</day>
        <month>12</month>
        <year>2015</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.-->
      <pub-date pub-type="ppub">
        <day>03</day>
        <month>12</month>
        <year>2015</year>
      </pub-date>
      <volume>163</volume>
      <issue>6</issue>
      <fpage>1375</fpage>
      <lpage>1387</lpage>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>8</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>14</day>
          <month>10</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>10</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2015 The Authors</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p>
        </license>
      </permissions>
      <abstract>
        <title>Summary</title>
        <p>TFIIB-related factor 2 (Brf2) is a member of the family of TFIIB-like core transcription factors. Brf2 recruits RNA polymerase (Pol) III to type III gene-external promoters, including the U6 spliceosomal RNA and selenocysteine tRNA genes. Found only in vertebrates, Brf2 has been linked to tumorigenesis but the underlying mechanisms remain elusive. We have solved crystal structures of a human Brf2-TBP complex bound to natural promoters, obtaining a detailed view of the molecular interactions occurring at Brf2-dependent Pol III promoters and highlighting the general structural and functional conservation of human Pol II and Pol III pre-initiation complexes. Surprisingly, our structural and functional studies unravel a Brf2 redox-sensing module capable of specifically regulating Pol III transcriptional output in living cells. Furthermore, we establish Brf2 as a central redox-sensing transcription factor involved in the oxidative stress pathway and provide a mechanistic model for Brf2 genetic activation in lung and breast cancer.</p>
      </abstract>
      <abstract abstract-type="graphical">
        <title>Graphical Abstract</title>
        <fig id="undfig1" position="anchor">
          <graphic xlink:href="fx1"/>
        </fig>
      </abstract>
      <abstract abstract-type="author-highlights">
        <title>Highlights</title>
        <p>
          <list list-type="simple">
            <list-item id="u0010">
              <label>â¢</label>
              <p>Architectural conservation of TFIIB and TFIIB-related factors</p>
            </list-item>
            <list-item id="u0015">
              <label>â¢</label>
              <p>Brf2 is a redox-sensing RNA polymerase III core transcription factor</p>
            </list-item>
            <list-item id="u0020">
              <label>â¢</label>
              <p>Brf2 regulates cellular responses to oxidative stress</p>
            </list-item>
            <list-item id="u0025">
              <label>â¢</label>
              <p>Brf2 amplification enables cancer cells to evade oxidative stress-induced apoptosis</p>
            </list-item>
          </list>
        </p>
      </abstract>
      <abstract abstract-type="teaser">
        <p>Direct redox-sensing by the RNA polymeraseÂ III core transcription factor Brf2 couples cellular responses to oxidative stress and regulation of transcriptional output, contributing to the ability of cancer cells to evade death induced by reactive oxygen species.</p>
      </abstract>
    </article-meta>
    <notes>
      <p id="misc0010">Published: December 3, 2015</p>
    </notes>
  </front>
  <body>
    <sec id="sec1">
      <title>Introduction</title>
      <p>In the eukaryotic nucleus, RNA polymerase (Pol) III transcribes genes encoding essential RNAs, including tRNAs and the 5S rRNA. The accurate recruitment of Pol III to its target genes and the formation of a transcriptionally active pre-initiation complex (PIC) occur through the association of Pol III with several specific transcription factors but TFIIIB is the key factor required for this process (<xref rid="bib27" ref-type="bibr">Kassavetis etÂ al., 1999</xref>, <xref rid="bib46" ref-type="bibr">Schramm and Hernandez, 2002</xref>). TFIIIB is a complex composed of the TFIIB-related factor 1 (Brf1) (<xref rid="bib34" ref-type="bibr">LÃ³pez-De-LeÃ³n etÂ al., 1992</xref>, <xref rid="bib52" ref-type="bibr">Wang and Roeder, 1995</xref>), the TATA binding protein (TBP) (<xref rid="bib25" ref-type="bibr">Kassavetis etÂ al., 1992</xref>, <xref rid="bib32" ref-type="bibr">Lobo etÂ al., 1992</xref>), and Bdp1, a SANT domain-containing protein (<xref rid="bib26" ref-type="bibr">Kassavetis etÂ al., 1995</xref>, <xref rid="bib47" ref-type="bibr">Schramm etÂ al., 2000</xref>). Vertebrates contain an alternative TFIIIB complex in which Brf1 is replaced by the TFIIB-related factor 2 (Brf2) (<xref rid="bib9" ref-type="bibr">Cabart and Murphy, 2001</xref>, <xref rid="bib47" ref-type="bibr">Schramm etÂ al., 2000</xref>, <xref rid="bib49" ref-type="bibr">Teichmann etÂ al., 2000</xref>).</p>
      <p>The Brf2-containing TFIIIB complex recruits Pol III to type III promoters, characterized by a TATA box located 20â25 base pairs (bp) upstream of the transcriptional start site and a proximal sequence element (PSE) located further upstream (<xref rid="bib46" ref-type="bibr">Schramm and Hernandez, 2002</xref>). The TATA box is recognized by the Brf2-TBP complex, which binds synergistically with SNAP<sub>c</sub>, a complex binding to the PSE (<xref rid="bib18" ref-type="bibr">Henry etÂ al., 1995</xref>). Actively transcribed Brf2-dependent genes have been characterized genome-wide (<xref rid="bib11" ref-type="bibr">CarriÃ¨re etÂ al., 2012</xref>, <xref rid="bib20" ref-type="bibr">James Faresse etÂ al., 2012</xref>, <xref rid="bib41" ref-type="bibr">Oler etÂ al., 2010</xref>) and encode a small collection of RNAs including the spliceosomal U6 small nuclear RNA (snRNA), the RNA component of the tRNA processing enzyme RNase P, and the selenocysteine tRNA (<xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>).</p>
      <p>Brf2 and Brf1 are part of a family of TFIIB-like transcription factors that share structural and functional features with the archetypal Pol II transcription factor TFIIB (<xref rid="bib28" ref-type="bibr">Knutson and Hahn, 2011</xref>, <xref rid="bib38" ref-type="bibr">Naidu etÂ al., 2011</xref>, <xref rid="bib51" ref-type="bibr">Vannini and Cramer, 2012</xref>). These factors all contain an N-terminal B-ribbon/reader/linker domain, which protrudes toward the polymerase active site, and a B-core domain consisting of two cyclin fold imperfect repeats, which in TFIIB binds simultaneously to the core of the Pol II enzyme, TBP, and the DNA. Additionally, Brf2 and Brf1 contain C-terminal domains (CTDs), which represent the major site of interaction with the adjoining TFIIIB subunits Bdp1 and TBP (<xref rid="bib45" ref-type="bibr">Saxena etÂ al., 2005</xref>). Whether TFIIB-like factors display the same architecture as TFIIB when bound to TBP and DNA is currently not known.</p>
      <p>Pol III transcription is tightly regulated during the cell-cycle and its upregulation has been linked to tumorigenesis (<xref rid="bib53" ref-type="bibr">White, 2011</xref>). Recently, Brf2 was found to be specifically amplified in the squamous cell carcinoma subtype of non-small cell lung cancer (<xref rid="bib33" ref-type="bibr">Lockwood etÂ al., 2010</xref>). Additionally, Brf2 overexpression is observed in several forms of cancers and correlates with poor patient survival rates, implicating Brf2 as a general oncogene, a prognosis marker, and a target for new anticancer therapies (<xref rid="bib8" ref-type="bibr">Cabarcas and Schramm, 2011</xref>, <xref rid="bib35" ref-type="bibr">Lu etÂ al., 2013</xref>, <xref rid="bib36" ref-type="bibr">Lu etÂ al., 2014</xref>). Despite its significance, very little is known about the molecular architecture and mechanisms underlying Brf2-dependent Pol III transcription and its regulation.</p>
    </sec>
    <sec id="sec2">
      <title>Results</title>
      <sec id="sec2.1">
        <title>Architecture of Brf2-TBP/DNA Complexes</title>
        <p>We obtained X-ray crystallographic structures of Brf2-TBP complexes bound to the U6 snRNA (copy number 2, U6-2), RPPH1, and TRNAU1 promoters at resolutions of 1.9Â Ã, 2.2Â Ã, and 2.7Â Ã, respectively (<xref rid="fig1" ref-type="fig">Figures 1</xref>A and <xref rid="figs1" ref-type="fig">S1</xref>AâS1D; <xref rid="mmc1" ref-type="supplementary-material">Table S2</xref>). In all three cases, the double-stranded DNA scaffold used for crystallization was 28Â bp long and corresponded to promoter sequences extending 10Â bp upstream and downstream of the TATA box (<xref rid="figs1" ref-type="fig">FigureÂ S1</xref>A). Notably, the DNA path was not perturbed by the crystalline environment and was influenced only by the specific interactions with TBP and Brf2. Where not stated otherwise, we focus on the analysis of the complex solved at the highest resolution, the Brf2-TBP/U6-2 complex (hereafter referred to as the Brf2-TBP/DNA complex), but the conclusions apply to all three complexes.</p>
        <p>The overall architecture of the Brf2-TBP/DNA complex (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>) is reminiscent of the TFIIB-TBP/DNA complex (<xref rid="bib40" ref-type="bibr">Nikolov etÂ al., 1995</xref>, <xref rid="bib50" ref-type="bibr">Tsai and Sigler, 2000</xref>), thus providing experimental support to the proposed common architectural organization of TFIIB-related factors and TFIIB (<xref rid="bib51" ref-type="bibr">Vannini and Cramer, 2012</xref>) (<xref rid="figs1" ref-type="fig">FigureÂ S1</xref>B). In the Brf2-TBP/RPPH1 structure, the Brf2-TBP complex is bound to the DNA with inverse polarity, probably due to the perfect dyad symmetry of the TATA box at this promoter (<xref rid="figs1" ref-type="fig">Figures S1</xref>A and S1C).</p>
        <p>Whether associated with Brf2 or TFIIB, TBP interacts with the TATA box in an undistinguishable manner, generating a virtually identical local bend in the DNA. However, as a result of specific Brf2/DNA interactions, the path of the DNA backbone deviates at the TATA flanking regions (<xref rid="figs1" ref-type="fig">FigureÂ S1</xref>B). Modeling of a Pol III closed PIC using the Brf2-TBP/DNA complex revealed no clashes with the polymerase core and a DNA path that strongly resembles that of the human Pol II closed PIC (<xref rid="bib17" ref-type="bibr">He etÂ al., 2013</xref>) (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>). In this model, the path of the DNA downstream of the TATA box points directly toward the Pol III subunits C39 and C62, consistent with their DNA binding activity and their functional role in DNA melting and open PIC stabilization (<xref rid="bib7" ref-type="bibr">Brun etÂ al., 1997</xref>, <xref rid="bib30" ref-type="bibr">LefÃ¨vre etÂ al., 2011</xref>).</p>
      </sec>
      <sec id="sec2.2">
        <title>Brf2/DNA-Specific Interactions</title>
        <p>Brf2 contacts extensively the phosphate backbone of the DNA and establishes sequence-specific contacts with both the upstream and downstream TATA flanking regions (<xref rid="fig1" ref-type="fig">Figures 1</xref>A and <xref rid="figs1" ref-type="fig">S1</xref>AâS1C). The Brf2 N-terminal cyclin repeat is structurally related to the corresponding domain in TFIIB, however in the Brf2-TBP/DNA complex the minor groove of the DNA is more intimately contacted via a helix-turn-helix motif (<xref rid="fig1" ref-type="fig">Figures 1</xref>A and <xref rid="fig3" ref-type="fig">3</xref>A). The highly conserved dyad K113 and K114 (<xref rid="figs1" ref-type="fig">FigureÂ S1</xref>E) contacts the phosphate backbone of the DNA on opposite sides, allowing the insertion of a short helix into the minor groove and the consequent direct recognition of bases A<sub>+3</sub> and Gâ²<sub>+4</sub> (numbering is relative to the edge of the TATA box, with the non-template strand designated by a prime) (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>A). The side chain of R110 forms a direct hydrogen bond with A<sub>+3</sub> and a water-mediated hydrogen bond with Gâ²<sub>+4,</sub> whereas the main chain carbonyl oxygen of A108 forms a direct hydrogen bond with Gâ²<sub>+4</sub>. These interactions locally distort the DNA, leaving the base Tâ²<sub>+3</sub> unstacked at its downstream edge. A nucleobase T at positionÂ +3 on the non-template strand, followed by a nucleobase A, T, or G (collectively abbreviated as D) at positionÂ +4, is notably enriched at Brf2-dependent promoters (<xref rid="figs2" ref-type="fig">FigureÂ S2</xref>A). We investigated the importance of the TD motif, which is also a conserved feature of the Pol II BRE<sub>d</sub> (<xref rid="bib12" ref-type="bibr">Deng and Roberts, 2005</xref>), on the formation of a Brf2-TBP/DNA ternary complex, using electrophoretic mobility shift assays (EMSAs) (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>B). In agreement with the observed role of R110 in specific recognition of A<sub>+3</sub>, a Brf2 R110A mutant displayed a reduced affinity for DNA compared to Brf2 wild-type, an effect that was most prominent in presence of an A nucleobase at positionÂ +3 of the template strand, suggesting a functional discrimination between Tâ²<sub>+3</sub> -containing and Tâ²<sub>+3</sub> -less promoters (<xref rid="fig3" ref-type="fig">Figures 3</xref>B and <xref rid="figs2" ref-type="fig">S2</xref>A). Thus, the conserved TD element, a dinucleotide step characterized by low unstacking energies (<xref rid="bib43" ref-type="bibr">Protozanova etÂ al., 2004</xref>), may represent a site at the downstream edge of the TATA box where DNA melting is favored as a result of the specific interactions with Brf2 R110 and A108. Indeed, in the Brf2-TBP/RPPH1 structure, in which the canonical TD motif is replaced with TC nucleobases, the Tâ²<sub>+3</sub>Câ²<sub>+4</sub> dinucleotide is still specifically recognized by R110 but with an altered set of interactions that leaves the nucleobase Tâ²<sub>+3</sub> unperturbed and regularly stacked at both edges, likely due to the higher stacking energy of this dinucleotide step (<xref rid="figs2" ref-type="fig">FigureÂ S2</xref>C).</p>
        <p>The Brf2 C-terminal cyclin repeat interacts with the major groove upstream of the TATA-box, similarly to TFIIB albeit more intimately (<xref rid="bib29" ref-type="bibr">Lagrange etÂ al., 1998</xref>, <xref rid="bib50" ref-type="bibr">Tsai and Sigler, 2000</xref>) (<xref rid="fig1" ref-type="fig">Figures 1</xref>A and <xref rid="fig3" ref-type="fig">3</xref>C). Brf2 residue Y260 establishes a hydrogen bond and a T-shaped Ï-Ï interaction with nucleobase C<sub>â4</sub> and an additional T-shaped Ï-Ï interaction with nucleobase C<sub>â3</sub> (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>C). T-shaped Ï-Ï interactions are favored in the presence of pyrimidines (<xref rid="bib54" ref-type="bibr">Wilson etÂ al., 2014</xref>), explaining their enrichment, in particular for C, observed at â4 and â3 positions (<xref rid="figs2" ref-type="fig">FigureÂ S2</xref>A). The hydrogen bond between Y260 and C<sub>â4</sub> explains the presence of a C<sub>â4</sub> nucleobase (complementary G in the non-template strand) at the vast majority of Brf2-dependent promoters, since a base-specific hydrogen bond is only possible with the amine group of a pyrimidine nucleobase C or purine nucleobase A at that position. Indeed, substitution of C<sub>â4</sub> with a GÂ or a T residue, or exchange of both adjacent pyrimidines with purines, resulted in reduced binding (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>D). A nucleobase A at position â4 is well tolerated since it can establish an hydrogen bond with Y260, but exclusively in presence of a pyrimidine at position â3, in order to preserve the additional Ï-Ï interaction. In summary, the structural and functional data underscore the preference for a C nucleobase and a pyrimidine nucleobase (C or T) at positions â4 and â3, respectively, of the template strand. We named this Brf2-specific dinucleotide step the âGRâ element (<xref rid="figs2" ref-type="fig">FigureÂ S2</xref>A).</p>
      </sec>
      <sec id="sec2.3">
        <title>Modular Architecture of Brf2 CTD</title>
        <p>The Brf2 CTD is organized into three conserved modular structural elements (<xref rid="fig1" ref-type="fig">Figures 1</xref> and <xref rid="figs1" ref-type="fig">S1</xref>E). Brf2 conserved residues 291â314 fold into an unusual semi-circular Î± helix, which we named the âarch.â Brf2 truncation at position D289, but not at positions R394, G380, G348, or A311, prevented the formation of a SNAPc-Brf2-TBP/DNA complex (<xref rid="figs3" ref-type="fig">FigureÂ S3</xref>A), consistent with the arch constituting a main SNAP<sub>c</sub>-binding interface.</p>
        <p>The C-terminal part of the Brf2 CTD (residues 374â419) folds into a TBP âanchor domain,â which structurally resembles Brf1 homology region II and binds TBP on its convex surface similarly to other TBP-associated factors (<xref rid="bib1" ref-type="bibr">Anandapadamanaban etÂ al., 2013</xref>, <xref rid="bib23" ref-type="bibr">Juo etÂ al., 2003</xref>) (<xref rid="figs3" ref-type="fig">FigureÂ S3</xref>B). Remarkably, deletion of the TBP anchor domain (residues 365â419) not only abolishes the binding of Brf2 to TBP but also abrogates the formation of a ternary Brf2-TBP/DNA complex (<xref rid="fig4" ref-type="fig">Figures 4</xref>A and 4B).</p>
        <p>A Brf2-specific short structured element (residues 357â363), the âmolecular pin,â encompasses a conserved LPPC motif and lies at the ternary interface between the Brf2 C-terminal cyclin repeat, TBP, and the DNA (<xref rid="figs1" ref-type="fig">Figure S1</xref>E and <xref rid="fig4" ref-type="fig">FigureÂ 4</xref>C). This helical element virtually pins the ternary complex together, juxtaposing onto a hydrophobic pocket at the interface between TBP and the Brf2 C-terminal cyclin repeat, which, in contrast to what is observed for TFIIB, strongly interact together. The Brf2 residue W215 forms a hydrophobic stack with TBP residues R269 and P267 (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>C) and is conserved throughout Brf2 evolution and in human and yeast Brf1, implying a conserved general architecture of Pol III Brf1- and Brf2-TBP complexes (<xref rid="figs1" ref-type="fig">Figures S1</xref>E and <xref rid="figs2" ref-type="fig">S2</xref>B). These additional strong interactions between the Brf2 and Brf1 C-terminal cyclin repeats and TBP may contribute to the observed increased stability of the Pol III-PIC, as compared to Pol II (<xref rid="bib3" ref-type="bibr">Arimbasseri etÂ al., 2013</xref>). The deletion of the molecular pin does not impair Brf2 binding to TBP in the absence of DNA but severely impairs the formation of a ternary complex, underscoring the central role of the molecular pin in the formation of a functional Brf2-TBP/DNA complex (<xref rid="fig4" ref-type="fig">Figures 4</xref>A and 4B). At the tip of the molecular pin, the Brf2 residue C361 is buried in the groove between two adjacent phosphate groups of the DNA backbone, establishing both van der Waals and water-mediated hydrogen bonds at the upstream edge of the TATA box (<xref rid="fig5" ref-type="fig">FigureÂ 5</xref>A).</p>
      </sec>
      <sec id="sec2.4">
        <title>Brf2 Is Redox Regulated</title>
        <p>A recurring theme in redox signaling by transcription factors is the presence of a reactive cysteine thiol that can cycle through reduced and oxidized states, âsensingâ the redox environment of the cell (<xref rid="bib5" ref-type="bibr">Brigelius-Flohe and Flohe, 2011</xref>). We noticed a remarkable structural similarity between the conserved Brf2 C361 and NF-ÎºB p50 C59 (<xref rid="bib14" ref-type="bibr">Ghosh etÂ al., 1995</xref>) (<xref rid="figs3" ref-type="fig">FigureÂ S3</xref>C), a DNA-binding cysteine residue regulated via oxidative modifications inÂ vivo (<xref rid="bib42" ref-type="bibr">Pineda-Molina etÂ al., 2001</xref>), prompting us to investigate the redox properties of Brf2.</p>
        <p>Using tandem mass-spectrometry, we could detect reversible oxidative modifications of C361 upon overnight incubation of Brf2 in absence of reducing agents and in presence of dimedone, a cyclic diketone that specifically reacts with sulfenic acid (<xref rid="figs4" ref-type="fig">FigureÂ S4</xref>). The strictly conserved C361 and the nearby non-conserved C370 were the only two cysteine residues clearly identified with bound dimedone, suggesting that these residues reside in a local protein environment prone to oxidation. Indeed, the chemical environment surrounding these residues is enriched in positively charged residues (K363, K367, and R368), which are known to stabilize thiolate anions, reducing the pK<sub>a</sub> of the cysteine residues and thus resulting in a sulfur atom that is more susceptible to oxidation (<xref rid="bib31" ref-type="bibr">Lo Conte and Carroll, 2013</xref>). Protein sulfenylation is a reversible post-translational modification that is emerging as a novel regulatory mechanism with particular relevance in redox signal transduction (<xref rid="bib15" ref-type="bibr">Gupta and Carroll, 2014</xref>). In this context, the formation of mixed disulfide bonds between sulfenic acid intermediates and low molecular-weight thiols such as glutathione constitutes a common cellular mechanismÂ to prevent progression toward irreversible oxidation states, thus ensuring reversible regulation. We confirmed by tandem mass-spectrometry that upon incubation with oxidized glutathione, Brf2 is efficiently <italic>S</italic>-glutathionylated specifically atÂ residues C361 and C370 (<xref rid="figs4" ref-type="fig">FigureÂ S4</xref>). Altogether, the mass-spectrometry data indicate that Brf2 C361 and C370 are highly reactive cysteine residues that are prone to oxidation and can be <italic>S</italic>-glutathionylated inÂ vitro.</p>
        <p>We thus tested the functional relevance of Brf2 oxidative modifications on the formation of functional Brf2-TBP/DNA complexes using EMSAs. Incubation of Brf2 with iodoacetamide, a low molecular-weight compound that irreversibly alkylates reactive cysteine and lysine residues in proteins and peptides, resulted in a severe reduction of Brf2-TBP/DNA complex assembly (<xref rid="fig5" ref-type="fig">FigureÂ 5</xref>B). This effect was mediated by residue C361, since a Brf2 C361A mutant was insensitive to treatments with the alkylating agent and displayed unaltered affinity for TBP/DNA complexes (<xref rid="fig5" ref-type="fig">FigureÂ 5</xref>B and <xref rid="figs3" ref-type="fig">S3</xref>F). Thus, out of a total of 16 cysteine residues, Brf2 C361 is the sole reactive cysteine negatively regulating the formation of the Brf2-TBP/DNA ternary complex upon alkylation. Brf2 oxidation caused by removal of reducing agents and incubation over time impaired the formation of the ternary complex, an effect that was mostly reversible and mediated by C361 (<xref rid="fig5" ref-type="fig">FigureÂ 5</xref>C). This finding suggests that oxidative modifications of C361 can reversibly modulate the assembly of the ternary complex and that a C361A mutation can confer redox-insensitivity to Brf2. In agreement, incubation of wild-type Brf2 with low concentrations of H<sub>2</sub>O<sub>2</sub> also impaired the formation of the complex, while the C361A mutant remained insensitive (<xref rid="fig5" ref-type="fig">FigureÂ 5</xref>D), suggesting that Brf2 C361 is susceptible to regulation by reactive oxygen species (ROS). Moreover, a Brf2 C361D mutant, structurally mimicking the oxidation state of C361 as a cysteic acid, was compromised in ternary complex formation with an apparent 50-fold reduction in affinity for TBP-DNA complexes, while still capable of efficiently binding to TBP (<xref rid="figs3" ref-type="fig">Figures S3</xref>DâS3F). To better simulate the perturbations of the redox potential that occur during oxidative stress in the cell, we treated Brf2 with gradients of oxidized/reduced glutathione (GSSG/GSH), whose ratio increases drastically during oxidative stress (<xref rid="bib22" ref-type="bibr">Jones, 2006</xref>). The formation of the ternary complex was highly sensitive to Brf2 treatments with GSSG/GSH, an effect that was fully reversed by addition of reducing agents and again exclusively mediated by C361, since the C361A mutant was insensitive to treatments with high GSSG/GSH ratios (<xref rid="fig5" ref-type="fig">FigureÂ 5</xref>E).</p>
        <p>Collectively, these results support a redox-sensing functional role of Brf2 C361, whose critical localization at the Brf2-TBP/DNA ternary interface enables modulation of the assembly of a functional complex.</p>
      </sec>
      <sec id="sec2.5">
        <title>Brf2-Dependent Pol III Transcription Is Redox-Regulated in Living Cells</title>
        <p>Having established Brf2 as a bona fide redox sensor, we asked whether synthesis of Brf2-dependent RNAs might be regulated in response to oxidative stress in living cells. We monitored the intracellular levels of Brf2-dependent transcripts by qRT-PCR in MRC5 lung fibroblast cells challenged by exposure to tert-butylhydroperoxide (t-BHP), a potent inducer of oxidative stress. Remarkably, all the Brf2-dependent transcripts tested were severely reduced upon treatment, while leucine tRNA precursors (p-tRNA), a Brf1-dependent transcript, remained unchanged (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>A). We then focused on the selenocysteine (SeCys) tRNA, an essential tRNA encoded by a single active gene in mammalian genomes (<xref rid="bib20" ref-type="bibr">James Faresse etÂ al., 2012</xref>, <xref rid="bib41" ref-type="bibr">Oler etÂ al., 2010</xref>). Intracellular levels of SeCys p-tRNA were severely reduced in a t-BHP concentration- and exposure time-dependent manner (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>B). Removal of the oxidative agent after an acute exposure promptly restored high levels of SeCys p-tRNA (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>C). Importantly, oxidative stress-induced decrease of SeCys p-tRNA was Brf2-dependent, since transient transfection with Brf2 overexpression vectors rescued this effect (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>D). Strikingly, overexpression of the Brf2 redox-insensitive C361A mutant led to an increase of SeCys p-tRNA, suggesting the loss of a negative regulatory step. Conversely, overexpression of the Brf2 oxidized-mimic C361D did not affect SeCys p-tRNA, suggesting that this mutant is virtually inactive (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>D). In agreement with the existence of a post-translational regulatory mechanism, the decrease of SeCys p-tRNA levels observed upon treatment of MRC5 cells with t-BHP did not correlate with reduced Brf2 expression levels, which in fact increased during oxidative stress (<xref rid="fig7" ref-type="fig">FigureÂ 7</xref>A). Furthermore, we observed an 80% reduction of SeCys mature tRNA (m-tRNA) levels in cells challenged with t-BHP, an effect that was reversed by overexpression of Brf2 (<xref rid="figs5" ref-type="fig">FigureÂ S5</xref>A). Despite tRNAs generally being considered as molecules with a relatively long half-life, this result is in agreement with previously published data highlighting the higher rate of decay of SeCys tRNA when compared to other tRNAs (<xref rid="bib21" ref-type="bibr">Jameson etÂ al., 2002</xref>).</p>
      </sec>
      <sec id="sec2.6">
        <title>Redox Sensing by Brf2 Modulates Resistance to Oxidative Stress in Normal and Cancer Cells</title>
        <p>SeCys tRNA is essential for the synthesis of selenoproteins, the vast majority of which are involved in ROS detoxification and in the maintenance of cellular redox homeostasis (<xref rid="bib24" ref-type="bibr">Kasaikina etÂ al., 2012</xref>). To test whether the observed Brf2-dependent reduction of SeCys tRNA levels upon oxidative stress can impact the synthesis of selenoproteins and, consequently, resistance to ROS, we monitored the expression levels of a group of selenoproteins (Gpx1, Gpx4, SelM, and Sep15) in which a SeCys residue is present toward the N terminus of the protein (<xref rid="bib24" ref-type="bibr">Kasaikina etÂ al., 2012</xref>). In conditions of oxidative stress, as monitored by the increased steady-state levels of the nuclear factor erythroid 2-related factor 2 (Nrf2), intracellular levels of all the selenoproteins tested were substantially reduced in MRC5 cells, an effect that was rescued by overexpression of Brf2, while no differences were observed in unchallenged cells (<xref rid="fig7" ref-type="fig">FigureÂ 7</xref>A). Strikingly, Brf2 overexpression in MRC5 cells resulted in a marked acquired resistance toward oxidative stress enabling MRC5 cells to evade apoptosis (<xref rid="fig7" ref-type="fig">FigureÂ 7</xref>B). Paralleling the redox-induced changes in SeCys p-tRNA synthesis, overexpression of the Brf2 redox-insensitive C361A mutant enabled a more pronounced resistance to oxidative stress when compared to Brf2 wild-type, while the Brf2 oxidized-mimic C361D was severely impaired in conferring resistance to apoptosis (<xref rid="fig7" ref-type="fig">FigureÂ 7</xref>C). Since Brf2 has been recently discovered as a top-scoring candidate driver in breast carcinomas (<xref rid="bib44" ref-type="bibr">Sanchez-Garcia etÂ al., 2014</xref>), we additionally investigated the effects of Brf2 overexpression on selenoproteins expression levels and evasion of apoptosis in MCF10A cells, a mammary epithelium cell line with low expression of Brf2. We observed a strong acquired resistance to oxidative stress that correlates with higher levels of selenoproteins, analogously to what observed in MRC5 cells (<xref rid="figs5" ref-type="fig">Figures S5</xref>BâS5D).</p>
        <p>Conversely, to test the functional consequences of decreasing Brf2 activity during oxidative stress in cancer cells, we reduced the levels of Brf2 via small interfering RNA (siRNA) in A549 cells challenged with t-BHP. A549 are epithelial human lung adenocarcinoma cells displaying high Brf2 expression and a generally increased resistance to t-BHP treatment when compared to MRC5 fibroblasts (<xref rid="fig7" ref-type="fig">Figures 7</xref>A and 7D). In A549 cells, we could additionally monitor the expression levels of Gpx2, a selenoprotein upregulated by Nrf2 during oxidative stress (<xref rid="bib6" ref-type="bibr">Brigelius-FlohÃ© etÂ al., 2012</xref>) and overexpressed in colorectal and prostate cancer (<xref rid="bib13" ref-type="bibr">Emmink etÂ al., 2014</xref>, <xref rid="bib39" ref-type="bibr">Naiki etÂ al., 2014</xref>). As for the primary cell lines, we observed an inverse correlation between cellular commitment to apoptosis and the expression level of selenoproteins (<xref rid="fig7" ref-type="fig">Figures 7</xref>A and 7D). Levels of all the selenoproteins tested, including Gpx2 that was upregulated during oxidative stress, were reduced in Brf2-silenced cells challenged with 50Â Î¼M t-BHP, a condition that induced apoptosis (<xref rid="fig7" ref-type="fig">Figures 7</xref>A and 7D). This effect, as well as the decrease of SeCys p-tRNA levels, was reversed by concomitant overexpression of a siRNA-resistant form of Brf2 (<xref rid="figs6" ref-type="fig">FigureÂ S6</xref>), suggesting a direct involvement of Brf2 in the oxidative stress response pathway and in the acquired resistance to oxidative stress observed in human lung adenocarcinoma cells.</p>
      </sec>
    </sec>
    <sec id="sec3">
      <title>Discussion</title>
      <p>The structures of Brf2-TBP/DNA ternary complexes reveal a general conservation of the architecture of TFIIB-related factors and specific recognition of DNA elements by Brf2. A TD element at the downstream edge of the TATA box, a central component of the BRE<sub>d</sub> Pol II core promoter element (<xref rid="bib12" ref-type="bibr">Deng and Roberts, 2005</xref>), is specifically recognized by a Brf2Â minor groove interacting element, resulting in a local distortion of the nucleic acid structure and a partially unstacked T nucleobase (<xref rid="fig2" ref-type="fig">Figures 2</xref>, <xref rid="fig3" ref-type="fig">3</xref>A, and <xref rid="figs2" ref-type="fig">S2</xref>C), suggesting that BRE<sub>d</sub> and BRE<sub>d</sub>-like elements could represent sites primed for DNA melting. In this respect, the winged helix domains of yeast Pol III subunit C34 and Pol II transcription factor TFIIF (Tfg2 subunit), which have been involved in open complex formation and/or its stabilization (<xref rid="bib7" ref-type="bibr">Brun etÂ al., 1997</xref>, <xref rid="bib37" ref-type="bibr">MÃ¼hlbacher etÂ al., 2014</xref>), have been located exactly opposite of this site by cross-linking coupled with mass-spectrometry (<xref rid="bib37" ref-type="bibr">MÃ¼hlbacher etÂ al., 2014</xref>, <xref rid="bib55" ref-type="bibr">Wu etÂ al., 2012</xref>).</p>
      <p>A completely unexpected finding was the discovery of a redox-sensing regulatory module embedded in a TFIIB-related core transcription factor, implying a direct redox-dependent control of a eukaryotic nuclear RNA polymerase. Fewer than 20 Brf2-dependent genes are actively transcribed in mammalian cells, but their products are all involved in key functions (<xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>). We have focused on the SeCys tRNA gene, since selenoproteins are directly involved in the oxidative stress response. We discovered that levels of SeCys tRNAs and selenoproteins are strongly reduced during oxidative stress in living cells in a Brf2-dependent manner, and this effect is inversely correlated with oxidative stress-induced apoptosis (<xref rid="fig6" ref-type="fig">Figures 6</xref>, <xref rid="fig7" ref-type="fig">7</xref>, and <xref rid="figs5" ref-type="fig">S5</xref>).</p>
      <p>Abrogating selenoprotein expression or expression of truncated selenoproteins induces apoptotic cellular death, sensitization toward oxidative stress and a reversion of the cancerous phenotype (<xref rid="bib2" ref-type="bibr">Anestal etÂ al., 2008</xref>, <xref rid="bib13" ref-type="bibr">Emmink etÂ al., 2014</xref>, <xref rid="bib56" ref-type="bibr">Yoo etÂ al., 2013</xref>). Reduced selenoprotein expression or generation of defective truncated selenoproteins might occur upon prolonged activation of the Nrf2 pathway, which upregulate the synthesis of TrxR1 and Gpx2 mRNAs, in conjunction with limited intracellular amounts of SeCys tRNAs. Indeed, we show that levels of Secys p-tRNAs, SeCys m-tRNAs and selenoproteins are reduced during prolonged oxidative stress in a Brf2-dependent manner (<xref rid="fig6" ref-type="fig">Figures 6</xref>A, 6B, <xref rid="fig7" ref-type="fig">7</xref>A, <xref rid="figs5" ref-type="fig">S5</xref>A, and S5C). Thus, Brf2 redox-dependent regulation constitutes a cellular blockade capable of generating pro-apoptotic signals upon prolonged oxidative stress, by limiting the availability of SeCys tRNA (<xref rid="figs7" ref-type="fig">FigureÂ S7</xref>).</p>
      <p>Redox-dependent activation of Nrf2 is one of the principal events of the oxidative stress response pathway and is constitutively activated in squamous cell lung and breast carcinomas (<xref rid="bib6" ref-type="bibr">Brigelius-FlohÃ© etÂ al., 2012</xref>, <xref rid="bib10" ref-type="bibr">Cancer Genome Atlas Research Network, 2012</xref>, <xref rid="bib48" ref-type="bibr">SjÃ¶blom etÂ al., 2006</xref>). Major targets upregulated by Nrf2 upon oxidative stress include TrxR1 and Gpx2, two essential selenoproteins involved in the maintenance of redox homeostasis and anti-oxidant defense, which are found overexpressed in several forms of cancers (<xref rid="bib4" ref-type="bibr">Biaglow and Miller, 2005</xref>, <xref rid="bib6" ref-type="bibr">Brigelius-FlohÃ© etÂ al., 2012</xref>, <xref rid="bib13" ref-type="bibr">Emmink etÂ al., 2014</xref>, <xref rid="bib39" ref-type="bibr">Naiki etÂ al., 2014</xref>). Thus, we hypothesized that overexpression of Brf2, which is also observed in many forms of cancer (<xref rid="bib8" ref-type="bibr">Cabarcas and Schramm, 2011</xref>), is required to overcome the Brf2-dependent reduction of SeCys tRNAs observed during prolonged oxidative stress, in order to maintain sufficient expression levels of selenoproteins required for ROS detoxification and redox homeostasis. In agreement with this model, reducing Brf2 protein levels in A549 lung adenocarcinoma cells via siRNA resulted in diminished levels of selenoproteins (<xref rid="fig7" ref-type="fig">FigureÂ 7</xref>A) and a considerable sensitization toward t-BHP, an inducer of oxidative stress (<xref rid="fig7" ref-type="fig">FigureÂ 7</xref>D). This finding strongly supports a model of Brf2 as a key human redox-sensor involved in the oxidative stress pathway and mechanistically links its overexpression to malignancy, via a mechanism that enables cancer cells to evade apoptosis in conditions of prolonged oxidative stress, a hallmark of cancer (<xref rid="bib16" ref-type="bibr">Hanahan and Weinberg, 2000</xref>). In this context, ectopic overexpression of Brf2 in lung fibroblasts (<xref rid="fig7" ref-type="fig">Figures 7</xref>Aâ7C) and mammary epithelial cells (<xref rid="figs5" ref-type="fig">FigureÂ S5</xref>) reveals Brf2 oncogenic potential under oxidative stress conditions, supporting its role as an oncogenic driver in lung squamous cell carcinoma (<xref rid="bib33" ref-type="bibr">Lockwood etÂ al., 2010</xref>) and breast cancer (<xref rid="bib44" ref-type="bibr">Sanchez-Garcia etÂ al., 2014</xref>). Whether pro-apoptotic signals are generated exclusively in response to decreased intracellular levels of SeCys tRNA or whether additional Brf2-dependent transcripts are involved in the process remains to be determined.</p>
      <p>The unexpected finding of Brf2 as a specialized Pol III TFIIB-related factor with redox-sensing properties suggests that the emergence and strict conservation of Brf2 in higher metazoans has been evolutionary driven to uncouple the transcriptional output of the Brf2-dependent promoters from the bulk of Pol III transcription, in order to operate a stringent redox-dependent control on a very small subset of Pol III genes. Since both selenoproteins and Brf2 are absent in lower eukaryotes such as plants and fungi, evolution of a redox-dependent transcription factor devoted to the transcription of SeCys tRNA must have represented an important event during evolution of higher complexity organisms.</p>
    </sec>
    <sec id="sec4">
      <title>Experimental Procedures</title>
      <p>A detailed description of protocols can be found in the <xref rid="mmc1" ref-type="supplementary-material">Supplemental Experimental Procedures</xref>.</p>
      <sec id="sec4.1">
        <title>Protein Expression and Purification</title>
        <p>Brf2 lacking the Zn-ribbon/B-reader/B-linker (62â419, N-terminal His-tagged) was co-expressed with a TBP-core construct (169â339) and used for structural determination. Full-length Brf2 (C-terminal His-tagged) was cloned into pSBET and used for biochemical assays. The Quickchange Site-Directed Mutagenesis kit (Agilent Technologies) was used to generate the Brf2 point mutants.</p>
      </sec>
      <sec id="sec4.2">
        <title>Crystallization, Data Collection, Structure Solution, and Refinement</title>
        <p>Complexes were assembled at a final concentration of 60Â Î¼M and crystals were grown by mixing 1Â Î¼l each of complexes and crystallization solution (10%â20% PEG 3350, 50â100Â mM MgCl<sub>2</sub>, 2Â mM DTT) in hanging drop plates. Following harvesting and cryo-cooling, diffraction data were collected at the Diamond Light Source (UK) and ESRF (France) synchrotrons. The structure was solved by molecular replacement, using TFIIB-TBP/DNA (Protein Data Bank: 1C9B) as the search model.</p>
      </sec>
      <sec id="sec4.3">
        <title>EMSAs</title>
        <p>EMSAs where performed with 5â²-Cy5 fluorescently labeled oligonucleotides. The gels were scanned with a Typhoon FLA9500 (GE Healthcare).</p>
      </sec>
      <sec id="sec4.4">
        <title>Brf2 Pull-Down Experiments</title>
        <p>Pull-Down experiments were performed by incubation of bait and prey proteins in binding buffer and loaded onto a His SpinTrap columns (GE Healthcare). Following washing and elution, samples were analyzed by SDS-PAGE.</p>
      </sec>
      <sec id="sec4.5">
        <title>Mass Spectrometry</title>
        <p>Full-length Brf2 samples were digested with trypsin and infused into an LTQ Velos Orbitrap mass spectrometer (Thermo Fisher Scientific) to characterize cysteine oxidation states.</p>
      </sec>
      <sec id="sec4.6">
        <title>Fluorescence Polarization Assay</title>
        <p>Binding of 5â²-Alexa488-labeled oligonucleotides were monitored at different Brf2-TBP concentrations by fluorescence anisotropy at 25Â°C on a POLARstar Omega plate reader (BMG Labtech).</p>
      </sec>
      <sec id="sec4.7">
        <title>Immunopurification</title>
        <p>Immunopurification from cells lysed in RIPA buffer were carried out using a chip-grade Brf2 antibody (ab17011, Abcam) covalently coupled to epoxy-magnetic beads (Life Technologies), according to the manufacturerâs protocol.</p>
      </sec>
      <sec id="sec4.8">
        <title>Brf2 Overexpression and siRNA</title>
        <p>Cells were transfected with 1.5Â Î¼g of pCDNA3.1 (empty vector control), Brf2WT-pCDNA3.1, Brf2C361A-pCDNA3.1, or Brf2C361D-pCDNA3.1 DNA in a 6-well plate format, with Lipofectamine 2000 according to manufacturerâs instructions. In <xref rid="fig7" ref-type="fig">Figures 7</xref>C and <xref rid="figs5" ref-type="fig">S5</xref>D, cells were transfected with 1.5Â Î¼g of pCDNA3.1 (empty vector control) or 1.2Â Î¼g pCDNA3.1+ 0.3Â Î¼g of the relevant Brf2 construct.</p>
        <p>For Brf2 knockdown, cells were transfected with siGENOME Human Brf2 siRNA (M-013340-00-0005, Dharmacon) in <xref rid="fig7" ref-type="fig">Figures 7</xref>A and 7D, and with siGENONE Human Brf2 siRNA (1) (D-013340-03-0010, Dharmcacon) or siGENOME Human Brf2 siRNA (2) (D-013340-04-0010, Dharmacon) in <xref rid="figs6" ref-type="fig">FigureÂ S6</xref>, using Lipofectamine 2000 (Life Technologies). Allstars negative control (QIAGEN) was used for all control siRNA experiments.</p>
      </sec>
      <sec id="sec4.9">
        <title>qRT-PCR</title>
        <p>Total RNA was extracted from treated cells with TRIzol reagent (Life Technologies) according to the manufacturerâs instructions. SeCys p-tRNA was quantified using the relative standard curve method and the 5S rRNA as an endogenous control. SeCys m-tRNA was monitored using a previously published protocol (<xref rid="bib19" ref-type="bibr">Honda etÂ al., 2015</xref>) with minor modifications.</p>
      </sec>
      <sec id="sec4.10">
        <title>Flow Cytometry</title>
        <p>Cell viability and apoptosis were assessed by flow cytometry using annexin V and propidium iodide staining.</p>
      </sec>
    </sec>
    <sec id="sec5">
      <title>Author Contributions</title>
      <p>J.G. carried out purification of protein/nucleic acid complexes, performed biochemical experiments, including EMSAs, fluorescence polarization and IPs, prepared Brf2-TBP/DNA crystals, collected crystallographic data, and solved the Brf2-TBP/DNA structures. K.S. originally cloned Brf2, carried out cellular work, and performed qRT-PCR and FACS analysis. J.G. and K.S. generated Brf2 mutants. N.G. preliminary expressed and purified Brf2. M.W. and A.J.T. performed mass spectrometry analysis. P.C., O.D., and N.H. generated SNAP<sub>c</sub>-binding-deficient Brf2 mutants and performed EMSAs in presence of SNAP<sub>c</sub>. A.V. designed and supervised research and wrote the manuscript with contributions from all authors.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <element-citation publication-type="journal" id="sref1">
          <person-group person-group-type="author">
            <name>
              <surname>Anandapadamanaban</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Andresen</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Helander</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ohyama</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Siponen</surname>
              <given-names>M.I.</given-names>
            </name>
            <name>
              <surname>LundstrÃ¶m</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Kokubo</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ikura</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Moche</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sunnerhagen</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>High-resolution structure of TBP with TAF1 reveals anchoring patterns in transcriptional regulation</article-title>
          <source>Nat. Struct. Mol. Biol.</source>
          <volume>20</volume>
          <year>2013</year>
          <fpage>1008</fpage>
          <lpage>1014</lpage>
          <pub-id pub-id-type="pmid">23851461</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <element-citation publication-type="journal" id="sref2">
          <person-group person-group-type="author">
            <name>
              <surname>Anestal</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Prast-Nielsen</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Cenas</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Arner</surname>
              <given-names>E.S.</given-names>
            </name>
          </person-group>
          <article-title>Cell death by SecTRAPs: thioredoxin reductase as a prooxidant killer of cells</article-title>
          <source>PloS ONE</source>
          <volume>3</volume>
          <year>2008</year>
          <fpage>e1846</fpage>
          <pub-id pub-id-type="pmid">18382651</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <element-citation publication-type="journal" id="sref3">
          <person-group person-group-type="author">
            <name>
              <surname>Arimbasseri</surname>
              <given-names>A.G.</given-names>
            </name>
            <name>
              <surname>Rijal</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Maraia</surname>
              <given-names>R.J.</given-names>
            </name>
          </person-group>
          <article-title>Comparative overview of RNA polymerase II and III transcription cycles, with focus on RNA polymerase III termination and reinitiation</article-title>
          <source>Transcription</source>
          <volume>5</volume>
          <year>2013</year>
          <fpage>e27639</fpage>
          <pub-id pub-id-type="pmid">25764110</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <element-citation publication-type="journal" id="sref4">
          <person-group person-group-type="author">
            <name>
              <surname>Biaglow</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>R.A.</given-names>
            </name>
          </person-group>
          <article-title>The thioredoxin reductase/thioredoxin system: novel redox targets for cancer therapy</article-title>
          <source>Cancer Biol. Ther.</source>
          <volume>4</volume>
          <year>2005</year>
          <fpage>6</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">15684606</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <element-citation publication-type="journal" id="sref5">
          <person-group person-group-type="author">
            <name>
              <surname>Brigelius-Flohe</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Flohe</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Basic principles and emerging concepts in the redox control of transcription factors</article-title>
          <source>Antioxid. Redox. Signal.</source>
          <volume>15</volume>
          <year>2011</year>
          <fpage>2335</fpage>
          <lpage>2381</lpage>
          <pub-id pub-id-type="pmid">21194351</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <element-citation publication-type="journal" id="sref6">
          <person-group person-group-type="author">
            <name>
              <surname>Brigelius-FlohÃ©</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>MÃ¼ller</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Lippmann</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Kipp</surname>
              <given-names>A.P.</given-names>
            </name>
          </person-group>
          <article-title>The yin and yang of nrf2-regulated selenoproteins in carcinogenesis</article-title>
          <source>Int. J. Cell Biol.</source>
          <volume>2012</volume>
          <year>2012</year>
          <fpage>486147</fpage>
          <pub-id pub-id-type="pmid">22654914</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <element-citation publication-type="journal" id="sref7">
          <person-group person-group-type="author">
            <name>
              <surname>Brun</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Sentenac</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Werner</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Dual role of the C34 subunit of RNA polymerase III in transcription initiation</article-title>
          <source>EMBO J.</source>
          <volume>16</volume>
          <year>1997</year>
          <fpage>5730</fpage>
          <lpage>5741</lpage>
          <pub-id pub-id-type="pmid">9312031</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <element-citation publication-type="journal" id="sref8">
          <person-group person-group-type="author">
            <name>
              <surname>Cabarcas</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Schramm</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>RNA polymerase III transcription in cancer: the BRF2 connection</article-title>
          <source>Mol. Cancer</source>
          <volume>10</volume>
          <year>2011</year>
          <fpage>47</fpage>
          <pub-id pub-id-type="pmid">21518452</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <element-citation publication-type="journal" id="sref9">
          <person-group person-group-type="author">
            <name>
              <surname>Cabart</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>BRFU, a TFIIB-like factor, is directly recruited to the TATA-box of polymerase III small nuclear RNA gene promoters through its interaction with TATA-binding protein</article-title>
          <source>J.Â Biol. Chem.</source>
          <volume>276</volume>
          <year>2001</year>
          <fpage>43056</fpage>
          <lpage>43064</lpage>
          <pub-id pub-id-type="pmid">11564744</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <element-citation publication-type="journal" id="sref10">
          <person-group person-group-type="author">
            <collab>Cancer Genome Atlas Research Network</collab>
          </person-group>
          <article-title>Comprehensive genomic characterization of squamous cell lung cancers</article-title>
          <source>Nature</source>
          <volume>489</volume>
          <year>2012</year>
          <fpage>519</fpage>
          <lpage>525</lpage>
          <pub-id pub-id-type="pmid">22960745</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <element-citation publication-type="journal" id="sref11">
          <person-group person-group-type="author">
            <name>
              <surname>CarriÃ¨re</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Graziani</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Alibert</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Ghavi-Helm</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Boussouar</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Humbertclaude</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Jounier</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Aude</surname>
              <given-names>J.-C.</given-names>
            </name>
            <name>
              <surname>Keime</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Murvai</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Genomic binding of Pol III transcription machinery and relationship with TFIIS transcription factor distribution in mouse embryonic stem cells</article-title>
          <source>Nucleic Acids Res.</source>
          <volume>40</volume>
          <year>2012</year>
          <fpage>270</fpage>
          <lpage>283</lpage>
          <pub-id pub-id-type="pmid">21911356</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <element-citation publication-type="journal" id="sref12">
          <person-group person-group-type="author">
            <name>
              <surname>Deng</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>S.G.E.</given-names>
            </name>
          </person-group>
          <article-title>A core promoter element downstream of the TATA box that is recognized by TFIIB</article-title>
          <source>Genes Dev.</source>
          <volume>19</volume>
          <year>2005</year>
          <fpage>2418</fpage>
          <lpage>2423</lpage>
          <pub-id pub-id-type="pmid">16230532</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <element-citation publication-type="journal" id="sref13">
          <person-group person-group-type="author">
            <name>
              <surname>Emmink</surname>
              <given-names>B.L.</given-names>
            </name>
            <name>
              <surname>Laoukili</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kipp</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Koster</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Govaert</surname>
              <given-names>K.M.</given-names>
            </name>
            <name>
              <surname>Fatrai</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Verheem</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Steller</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>Brigelius-FlohÃ©</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Jimenez</surname>
              <given-names>C.R.</given-names>
            </name>
          </person-group>
          <article-title>GPx2 suppression of H2O2 stress links the formation of differentiated tumor mass to metastatic capacity in colorectal cancer</article-title>
          <source>Cancer Res.</source>
          <volume>74</volume>
          <year>2014</year>
          <fpage>6717</fpage>
          <lpage>6730</lpage>
          <pub-id pub-id-type="pmid">25261240</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <element-citation publication-type="journal" id="sref14">
          <person-group person-group-type="author">
            <name>
              <surname>Ghosh</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>van Duyne</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Ghosh</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Sigler</surname>
              <given-names>P.B.</given-names>
            </name>
          </person-group>
          <article-title>Structure of NF-kappa B p50 homodimer bound to a kappa B site</article-title>
          <source>Nature</source>
          <volume>373</volume>
          <year>1995</year>
          <fpage>303</fpage>
          <lpage>310</lpage>
          <pub-id pub-id-type="pmid">7530332</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <element-citation publication-type="journal" id="sref15">
          <person-group person-group-type="author">
            <name>
              <surname>Gupta</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Carroll</surname>
              <given-names>K.S.</given-names>
            </name>
          </person-group>
          <article-title>Sulfenic acid chemistry, detection and cellular lifetime</article-title>
          <source>Biochim. Biophys. Acta</source>
          <volume>1840</volume>
          <year>2014</year>
          <fpage>847</fpage>
          <lpage>875</lpage>
          <pub-id pub-id-type="pmid">23748139</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <element-citation publication-type="journal" id="sref16">
          <person-group person-group-type="author">
            <name>
              <surname>Hanahan</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Weinberg</surname>
              <given-names>R.A.</given-names>
            </name>
          </person-group>
          <article-title>The hallmarks of cancer</article-title>
          <source>Cell</source>
          <volume>100</volume>
          <year>2000</year>
          <fpage>57</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="pmid">10647931</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <element-citation publication-type="journal" id="sref17">
          <person-group person-group-type="author">
            <name>
              <surname>He</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Fang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Taatjes</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Nogales</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Structural visualization of key steps in human transcription initiation</article-title>
          <source>Nature</source>
          <volume>495</volume>
          <year>2013</year>
          <fpage>481</fpage>
          <lpage>486</lpage>
          <pub-id pub-id-type="pmid">23446344</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <element-citation publication-type="journal" id="sref18">
          <person-group person-group-type="author">
            <name>
              <surname>Henry</surname>
              <given-names>R.W.</given-names>
            </name>
            <name>
              <surname>Sadowski</surname>
              <given-names>C.L.</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Hernandez</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>A TBP-TAF complex required for transcription of human snRNA genes by RNA polymerase II and III</article-title>
          <source>Nature</source>
          <volume>374</volume>
          <year>1995</year>
          <fpage>653</fpage>
          <lpage>656</lpage>
          <pub-id pub-id-type="pmid">7715707</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <element-citation publication-type="journal" id="sref19">
          <person-group person-group-type="author">
            <name>
              <surname>Honda</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Shigematsu</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Morichika</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Telonis</surname>
              <given-names>A.G.</given-names>
            </name>
            <name>
              <surname>Kirino</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Four-leaf clover qRT-PCR: A convenient method for selective quantification of mature tRNA</article-title>
          <source>RNA Biol.</source>
          <volume>12</volume>
          <year>2015</year>
          <fpage>501</fpage>
          <lpage>508</lpage>
          <pub-id pub-id-type="pmid">25833336</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <element-citation publication-type="journal" id="sref20">
          <person-group person-group-type="author">
            <name>
              <surname>James Faresse</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Canella</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Praz</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Michaud</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Romascano</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Hernandez</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Genomic study of RNA polymerase II and III SNAPc-bound promoters reveals a gene transcribed by both enzymes and a broad use of common activators</article-title>
          <source>PLoS Genet.</source>
          <volume>8</volume>
          <year>2012</year>
          <fpage>e1003028</fpage>
          <pub-id pub-id-type="pmid">23166507</pub-id>
        </element-citation>
      </ref>
      <ref id="bib21">
        <element-citation publication-type="journal" id="sref21">
          <person-group person-group-type="author">
            <name>
              <surname>Jameson</surname>
              <given-names>R.R.</given-names>
            </name>
            <name>
              <surname>Carlson</surname>
              <given-names>B.A.</given-names>
            </name>
            <name>
              <surname>Butz</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Esser</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hatfield</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Diamond</surname>
              <given-names>A.M.</given-names>
            </name>
          </person-group>
          <article-title>Selenium influences the turnover of selenocysteine tRNA([Ser]Sec) in Chinese hamster ovary cells</article-title>
          <source>J.Â Nutr.</source>
          <volume>132</volume>
          <year>2002</year>
          <fpage>1830</fpage>
          <lpage>1835</lpage>
          <pub-id pub-id-type="pmid">12097655</pub-id>
        </element-citation>
      </ref>
      <ref id="bib22">
        <element-citation publication-type="journal" id="sref22">
          <person-group person-group-type="author">
            <name>
              <surname>Jones</surname>
              <given-names>D.P.</given-names>
            </name>
          </person-group>
          <article-title>Redefining oxidative stress</article-title>
          <source>Antioxid. Redox. Signal.</source>
          <volume>8</volume>
          <year>2006</year>
          <fpage>1865</fpage>
          <lpage>1879</lpage>
          <pub-id pub-id-type="pmid">16987039</pub-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <element-citation publication-type="journal" id="sref23">
          <person-group person-group-type="author">
            <name>
              <surname>Juo</surname>
              <given-names>Z.S.</given-names>
            </name>
            <name>
              <surname>Kassavetis</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Geiduschek</surname>
              <given-names>E.P.</given-names>
            </name>
            <name>
              <surname>Sigler</surname>
              <given-names>P.B.</given-names>
            </name>
          </person-group>
          <article-title>Crystal structure of a transcription factor IIIB core interface ternary complex</article-title>
          <source>Nature</source>
          <volume>422</volume>
          <year>2003</year>
          <fpage>534</fpage>
          <lpage>539</lpage>
          <pub-id pub-id-type="pmid">12660736</pub-id>
        </element-citation>
      </ref>
      <ref id="bib24">
        <element-citation publication-type="journal" id="sref24">
          <person-group person-group-type="author">
            <name>
              <surname>Kasaikina</surname>
              <given-names>M.V.</given-names>
            </name>
            <name>
              <surname>Hatfield</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Gladyshev</surname>
              <given-names>V.N.</given-names>
            </name>
          </person-group>
          <article-title>Understanding selenoprotein function and regulation through the use of rodent models</article-title>
          <source>Biochim. Biophys. Acta</source>
          <volume>1823</volume>
          <year>2012</year>
          <fpage>1633</fpage>
          <lpage>1642</lpage>
          <pub-id pub-id-type="pmid">22440326</pub-id>
        </element-citation>
      </ref>
      <ref id="bib25">
        <element-citation publication-type="journal" id="sref25">
          <person-group person-group-type="author">
            <name>
              <surname>Kassavetis</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Joazeiro</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Pisano</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Geiduschek</surname>
              <given-names>E.P.</given-names>
            </name>
            <name>
              <surname>Colbert</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hahn</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Blanco</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <article-title>The role of the TATA-binding protein in the assembly and function of the multisubunit yeast RNA polymerase III transcription factor, TFIIIB</article-title>
          <source>Cell</source>
          <volume>71</volume>
          <year>1992</year>
          <fpage>1055</fpage>
          <lpage>1064</lpage>
          <pub-id pub-id-type="pmid">1458536</pub-id>
        </element-citation>
      </ref>
      <ref id="bib26">
        <element-citation publication-type="journal" id="sref26">
          <person-group person-group-type="author">
            <name>
              <surname>Kassavetis</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>S.T.</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Geiduschek</surname>
              <given-names>E.P.</given-names>
            </name>
            <name>
              <surname>Pisano</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Cloning, expression, and function of TFC5, the gene encoding the Bâ component of the Saccharomyces cerevisiae RNA polymerase III transcription factor TFIIIB</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>92</volume>
          <year>1995</year>
          <fpage>9786</fpage>
          <lpage>9790</lpage>
          <pub-id pub-id-type="pmid">7568218</pub-id>
        </element-citation>
      </ref>
      <ref id="bib27">
        <element-citation publication-type="journal" id="sref27">
          <person-group person-group-type="author">
            <name>
              <surname>Kassavetis</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Letts</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Geiduschek</surname>
              <given-names>E.P.</given-names>
            </name>
          </person-group>
          <article-title>A minimal RNA polymerase III transcription system</article-title>
          <source>EMBO J.</source>
          <volume>18</volume>
          <year>1999</year>
          <fpage>5042</fpage>
          <lpage>5051</lpage>
          <pub-id pub-id-type="pmid">10487756</pub-id>
        </element-citation>
      </ref>
      <ref id="bib28">
        <element-citation publication-type="journal" id="sref28">
          <person-group person-group-type="author">
            <name>
              <surname>Knutson</surname>
              <given-names>B.A.</given-names>
            </name>
            <name>
              <surname>Hahn</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Yeast Rrn7 and human TAF1B are TFIIB-related RNA polymerase I general transcription factors</article-title>
          <source>Science</source>
          <volume>333</volume>
          <year>2011</year>
          <fpage>1637</fpage>
          <lpage>1640</lpage>
          <pub-id pub-id-type="pmid">21921198</pub-id>
        </element-citation>
      </ref>
      <ref id="bib29">
        <element-citation publication-type="journal" id="sref29">
          <person-group person-group-type="author">
            <name>
              <surname>Lagrange</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kapanidis</surname>
              <given-names>A.N.</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Reinberg</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Ebright</surname>
              <given-names>R.H.</given-names>
            </name>
          </person-group>
          <article-title>New core promoter element in RNA polymerase II-dependent transcription: sequence-specific DNA binding by transcription factor IIB</article-title>
          <source>Genes Dev.</source>
          <volume>12</volume>
          <year>1998</year>
          <fpage>34</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="pmid">9420329</pub-id>
        </element-citation>
      </ref>
      <ref id="bib30">
        <element-citation publication-type="journal" id="sref30">
          <person-group person-group-type="author">
            <name>
              <surname>LefÃ¨vre</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Dumay-Odelot</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>El-Ayoubi</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Budd</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Legrand</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Pinaud</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Teichmann</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Fribourg</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Structure-function analysis of hRPC62 provides insights into RNA polymerase III transcription initiation</article-title>
          <source>Nat. Struct. Mol. Biol.</source>
          <volume>18</volume>
          <year>2011</year>
          <fpage>352</fpage>
          <lpage>358</lpage>
          <pub-id pub-id-type="pmid">21358628</pub-id>
        </element-citation>
      </ref>
      <ref id="bib31">
        <element-citation publication-type="journal" id="sref31">
          <person-group person-group-type="author">
            <name>
              <surname>Lo Conte</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Carroll</surname>
              <given-names>K.S.</given-names>
            </name>
          </person-group>
          <article-title>The redox biochemistry of protein sulfenylation and sulfinylation</article-title>
          <source>J.Â Biol. Chem.</source>
          <volume>288</volume>
          <year>2013</year>
          <fpage>26480</fpage>
          <lpage>26488</lpage>
          <pub-id pub-id-type="pmid">23861405</pub-id>
        </element-citation>
      </ref>
      <ref id="bib32">
        <element-citation publication-type="journal" id="sref32">
          <person-group person-group-type="author">
            <name>
              <surname>Lobo</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sullivan</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Hernandez</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>A TBP complex essential for transcription from TATA-less but not TATA-containing RNA polymerase III promoters is part of the TFIIIB fraction</article-title>
          <source>Cell</source>
          <volume>71</volume>
          <year>1992</year>
          <fpage>1029</fpage>
          <lpage>1040</lpage>
          <pub-id pub-id-type="pmid">1458534</pub-id>
        </element-citation>
      </ref>
      <ref id="bib33">
        <element-citation publication-type="journal" id="sref33">
          <person-group person-group-type="author">
            <name>
              <surname>Lockwood</surname>
              <given-names>W.W.</given-names>
            </name>
            <name>
              <surname>Chari</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Coe</surname>
              <given-names>B.P.</given-names>
            </name>
            <name>
              <surname>Thu</surname>
              <given-names>K.L.</given-names>
            </name>
            <name>
              <surname>Garnis</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Malloff</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Hwang</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>C.-Q.</given-names>
            </name>
          </person-group>
          <article-title>Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma</article-title>
          <source>PLoS Med.</source>
          <volume>7</volume>
          <year>2010</year>
          <fpage>e1000315</fpage>
          <pub-id pub-id-type="pmid">20668658</pub-id>
        </element-citation>
      </ref>
      <ref id="bib34">
        <element-citation publication-type="journal" id="sref34">
          <person-group person-group-type="author">
            <name>
              <surname>LÃ³pez-De-LeÃ³n</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Librizzi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Puglia</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Willis</surname>
              <given-names>I.M.</given-names>
            </name>
          </person-group>
          <article-title>PCF4 encodes an RNA polymerase III transcription factor with homology to TFIIB</article-title>
          <source>Cell</source>
          <volume>71</volume>
          <year>1992</year>
          <fpage>211</fpage>
          <lpage>220</lpage>
          <pub-id pub-id-type="pmid">1423589</pub-id>
        </element-citation>
      </ref>
      <ref id="bib35">
        <element-citation publication-type="journal" id="sref35">
          <person-group person-group-type="author">
            <name>
              <surname>Lu</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Yue</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Qi</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Si</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Overexpression of TFIIB-related factor 2 is significantly correlated with tumor angiogenesis and poor survival in patients with esophageal squamous cell cancer</article-title>
          <source>Med. Oncol.</source>
          <volume>30</volume>
          <year>2013</year>
          <fpage>553</fpage>
          <pub-id pub-id-type="pmid">23550276</pub-id>
        </element-citation>
      </ref>
      <ref id="bib36">
        <element-citation publication-type="journal" id="sref36">
          <person-group person-group-type="author">
            <name>
              <surname>Lu</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Yue</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Qi</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Si</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>TFIIB-related factor 2 over expression is a prognosis marker for early-stage non-small cell lung cancer correlated with tumor angiogenesis</article-title>
          <source>PLoS ONE</source>
          <volume>9</volume>
          <year>2014</year>
          <fpage>e88032</fpage>
          <pub-id pub-id-type="pmid">24523874</pub-id>
        </element-citation>
      </ref>
      <ref id="bib37">
        <element-citation publication-type="journal" id="sref37">
          <person-group person-group-type="author">
            <name>
              <surname>MÃ¼hlbacher</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Sainsbury</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Hemann</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hantsche</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Neyer</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Herzog</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Cramer</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Conserved architecture of the core RNA polymerase II initiation complex</article-title>
          <source>Nat. Commun.</source>
          <volume>5</volume>
          <year>2014</year>
          <fpage>4310</fpage>
          <pub-id pub-id-type="pmid">25007739</pub-id>
        </element-citation>
      </ref>
      <ref id="bib38">
        <element-citation publication-type="journal" id="sref38">
          <person-group person-group-type="author">
            <name>
              <surname>Naidu</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Friedrich</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Russell</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zomerdijk</surname>
              <given-names>J.C.B.M.</given-names>
            </name>
          </person-group>
          <article-title>TAF1B is a TFIIB-like component of the basal transcription machinery for RNA polymerase I</article-title>
          <source>Science</source>
          <volume>333</volume>
          <year>2011</year>
          <fpage>1640</fpage>
          <lpage>1642</lpage>
          <pub-id pub-id-type="pmid">21921199</pub-id>
        </element-citation>
      </ref>
      <ref id="bib39">
        <element-citation publication-type="journal" id="sref39">
          <person-group person-group-type="author">
            <name>
              <surname>Naiki</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Naiki-Ito</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Asamoto</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kawai</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Tozawa</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Etani</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Shirai</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kohri</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>GPX2 overexpression is involved in cell proliferation and prognosis of castration-resistant prostate cancer</article-title>
          <source>Carcinogenesis</source>
          <volume>35</volume>
          <year>2014</year>
          <fpage>1962</fpage>
          <lpage>1967</lpage>
          <pub-id pub-id-type="pmid">24562575</pub-id>
        </element-citation>
      </ref>
      <ref id="bib40">
        <element-citation publication-type="journal" id="sref40">
          <person-group person-group-type="author">
            <name>
              <surname>Nikolov</surname>
              <given-names>D.B.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Halay</surname>
              <given-names>E.D.</given-names>
            </name>
            <name>
              <surname>Usheva</surname>
              <given-names>A.A.</given-names>
            </name>
            <name>
              <surname>Hisatake</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>D.K.</given-names>
            </name>
            <name>
              <surname>Roeder</surname>
              <given-names>R.G.</given-names>
            </name>
            <name>
              <surname>Burley</surname>
              <given-names>S.K.</given-names>
            </name>
          </person-group>
          <article-title>Crystal structure of a TFIIB-TBP-TATA-element ternary complex</article-title>
          <source>Nature</source>
          <volume>377</volume>
          <year>1995</year>
          <fpage>119</fpage>
          <lpage>128</lpage>
          <pub-id pub-id-type="pmid">7675079</pub-id>
        </element-citation>
      </ref>
      <ref id="bib41">
        <element-citation publication-type="journal" id="sref41">
          <person-group person-group-type="author">
            <name>
              <surname>Oler</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Alla</surname>
              <given-names>R.K.</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>D.N.</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hollenhorst</surname>
              <given-names>P.C.</given-names>
            </name>
            <name>
              <surname>Chandler</surname>
              <given-names>K.J.</given-names>
            </name>
            <name>
              <surname>Cassiday</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Hagedorn</surname>
              <given-names>C.H.</given-names>
            </name>
            <name>
              <surname>Graves</surname>
              <given-names>B.J.</given-names>
            </name>
            <name>
              <surname>Cairns</surname>
              <given-names>B.R.</given-names>
            </name>
          </person-group>
          <article-title>Human RNA polymerase III transcriptomes and relationships to Pol II promoter chromatin and enhancer-binding factors</article-title>
          <source>Nat. Struct. Mol. Biol.</source>
          <volume>17</volume>
          <year>2010</year>
          <fpage>620</fpage>
          <lpage>628</lpage>
          <pub-id pub-id-type="pmid">20418882</pub-id>
        </element-citation>
      </ref>
      <ref id="bib42">
        <element-citation publication-type="journal" id="sref42">
          <person-group person-group-type="author">
            <name>
              <surname>Pineda-Molina</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Klatt</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>VÃ¡zquez</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Marina</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>GarcÃ­a de Lacoba</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>PÃ©rez-Sala</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Lamas</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Glutathionylation of the p50 subunit of NF-kappaB: a mechanism for redox-induced inhibition of DNA binding</article-title>
          <source>Biochemistry</source>
          <volume>40</volume>
          <year>2001</year>
          <fpage>14134</fpage>
          <lpage>14142</lpage>
          <pub-id pub-id-type="pmid">11714266</pub-id>
        </element-citation>
      </ref>
      <ref id="bib43">
        <element-citation publication-type="journal" id="sref43">
          <person-group person-group-type="author">
            <name>
              <surname>Protozanova</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Yakovchuk</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Frank-Kamenetskii</surname>
              <given-names>M.D.</given-names>
            </name>
          </person-group>
          <article-title>Stacked-unstacked equilibrium at the nick site of DNA</article-title>
          <source>J.Â Mol. Biol.</source>
          <volume>342</volume>
          <year>2004</year>
          <fpage>775</fpage>
          <lpage>785</lpage>
          <pub-id pub-id-type="pmid">15342236</pub-id>
        </element-citation>
      </ref>
      <ref id="bib44">
        <element-citation publication-type="journal" id="sref44">
          <person-group person-group-type="author">
            <name>
              <surname>Sanchez-Garcia</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Villagrasa</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Matsui</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kotliar</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Castro</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Akavia</surname>
              <given-names>U.D.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>B.J.</given-names>
            </name>
            <name>
              <surname>Saucedo-Cuevas</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Rodriguez Barrueco</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Llobet-Navas</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Integration of genomic data enables selective discovery of breast cancer drivers</article-title>
          <source>Cell</source>
          <volume>159</volume>
          <year>2014</year>
          <fpage>1461</fpage>
          <lpage>1475</lpage>
          <pub-id pub-id-type="pmid">25433701</pub-id>
        </element-citation>
      </ref>
      <ref id="bib45">
        <element-citation publication-type="journal" id="sref45">
          <person-group person-group-type="author">
            <name>
              <surname>Saxena</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Schramm</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Hernandez</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Structure-function analysis of the human TFIIB-related factor II protein reveals an essential role for the C-terminal domain in RNA polymerase III transcription</article-title>
          <source>Mol. Cell. Biol.</source>
          <volume>25</volume>
          <year>2005</year>
          <fpage>9406</fpage>
          <lpage>9418</lpage>
          <pub-id pub-id-type="pmid">16227591</pub-id>
        </element-citation>
      </ref>
      <ref id="bib46">
        <element-citation publication-type="journal" id="sref46">
          <person-group person-group-type="author">
            <name>
              <surname>Schramm</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Hernandez</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Recruitment of RNA polymerase III to its target promoters</article-title>
          <source>Genes Dev.</source>
          <volume>16</volume>
          <year>2002</year>
          <fpage>2593</fpage>
          <lpage>2620</lpage>
          <pub-id pub-id-type="pmid">12381659</pub-id>
        </element-citation>
      </ref>
      <ref id="bib47">
        <element-citation publication-type="journal" id="sref47">
          <person-group person-group-type="author">
            <name>
              <surname>Schramm</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Pendergrast</surname>
              <given-names>P.S.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Hernandez</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Different human TFIIIB activities direct RNA polymerase III transcription from TATA-containing and TATA-less promoters</article-title>
          <source>Genes Dev.</source>
          <volume>14</volume>
          <year>2000</year>
          <fpage>2650</fpage>
          <lpage>2663</lpage>
          <pub-id pub-id-type="pmid">11040218</pub-id>
        </element-citation>
      </ref>
      <ref id="bib48">
        <element-citation publication-type="journal" id="sref48">
          <person-group person-group-type="author">
            <name>
              <surname>SjÃ¶blom</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>L.D.</given-names>
            </name>
            <name>
              <surname>Parsons</surname>
              <given-names>D.W.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Barber</surname>
              <given-names>T.D.</given-names>
            </name>
            <name>
              <surname>Mandelker</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Leary</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Ptak</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Silliman</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>The consensus coding sequences of human breast and colorectal cancers</article-title>
          <source>Science</source>
          <volume>314</volume>
          <year>2006</year>
          <fpage>268</fpage>
          <lpage>274</lpage>
          <pub-id pub-id-type="pmid">16959974</pub-id>
        </element-citation>
      </ref>
      <ref id="bib49">
        <element-citation publication-type="journal" id="sref49">
          <person-group person-group-type="author">
            <name>
              <surname>Teichmann</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Roeder</surname>
              <given-names>R.G.</given-names>
            </name>
          </person-group>
          <article-title>A stable complex of a novel transcription factor IIB- related factor, human TFIIIB50, and associated proteins mediate selective transcription by RNA polymerase III of genes with upstream promoter elements</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>97</volume>
          <year>2000</year>
          <fpage>14200</fpage>
          <lpage>14205</lpage>
          <pub-id pub-id-type="pmid">11121026</pub-id>
        </element-citation>
      </ref>
      <ref id="bib50">
        <element-citation publication-type="journal" id="sref50">
          <person-group person-group-type="author">
            <name>
              <surname>Tsai</surname>
              <given-names>F.T.</given-names>
            </name>
            <name>
              <surname>Sigler</surname>
              <given-names>P.B.</given-names>
            </name>
          </person-group>
          <article-title>Structural basis of preinitiation complex assembly on human pol II promoters</article-title>
          <source>EMBO J.</source>
          <volume>19</volume>
          <year>2000</year>
          <fpage>25</fpage>
          <lpage>36</lpage>
          <pub-id pub-id-type="pmid">10619841</pub-id>
        </element-citation>
      </ref>
      <ref id="bib51">
        <element-citation publication-type="journal" id="sref51">
          <person-group person-group-type="author">
            <name>
              <surname>Vannini</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Cramer</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Conservation between the RNA polymerase I, II, and III transcription initiation machineries</article-title>
          <source>Mol. Cell</source>
          <volume>45</volume>
          <year>2012</year>
          <fpage>439</fpage>
          <lpage>446</lpage>
          <pub-id pub-id-type="pmid">22365827</pub-id>
        </element-citation>
      </ref>
      <ref id="bib52">
        <element-citation publication-type="journal" id="sref52">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Roeder</surname>
              <given-names>R.G.</given-names>
            </name>
          </person-group>
          <article-title>Structure and function of a human transcription factor TFIIIB subunit that is evolutionarily conserved and contains both TFIIB- and high-mobility-group protein 2-related domains</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>92</volume>
          <year>1995</year>
          <fpage>7026</fpage>
          <lpage>7030</lpage>
          <pub-id pub-id-type="pmid">7624363</pub-id>
        </element-citation>
      </ref>
      <ref id="bib53">
        <element-citation publication-type="journal" id="sref53">
          <person-group person-group-type="author">
            <name>
              <surname>White</surname>
              <given-names>R.J.</given-names>
            </name>
          </person-group>
          <article-title>Transcription by RNA polymerase III: more complex than we thought</article-title>
          <source>Nat. Rev. Genet.</source>
          <volume>12</volume>
          <year>2011</year>
          <fpage>459</fpage>
          <lpage>463</lpage>
          <pub-id pub-id-type="pmid">21540878</pub-id>
        </element-citation>
      </ref>
      <ref id="bib54">
        <element-citation publication-type="journal" id="sref54">
          <person-group person-group-type="author">
            <name>
              <surname>Wilson</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Kellie</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Wetmore</surname>
              <given-names>S.D.</given-names>
            </name>
          </person-group>
          <article-title>DNA-protein Ï-interactions in nature: abundance, structure, composition and strength of contacts between aromatic amino acids and DNA nucleobases or deoxyribose sugar</article-title>
          <source>Nucleic Acids Res.</source>
          <volume>42</volume>
          <year>2014</year>
          <fpage>6726</fpage>
          <lpage>6741</lpage>
          <pub-id pub-id-type="pmid">24744240</pub-id>
        </element-citation>
      </ref>
      <ref id="bib55">
        <element-citation publication-type="journal" id="sref55">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>C.-C.</given-names>
            </name>
            <name>
              <surname>Herzog</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Jennebach</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>Y.-C.</given-names>
            </name>
            <name>
              <surname>Pai</surname>
              <given-names>C.-Y.</given-names>
            </name>
            <name>
              <surname>Aebersold</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Cramer</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>H.-T.</given-names>
            </name>
          </person-group>
          <article-title>RNA polymerase III subunit architecture and implications for open promoter complex formation</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>109</volume>
          <year>2012</year>
          <fpage>19232</fpage>
          <lpage>19237</lpage>
          <pub-id pub-id-type="pmid">23132938</pub-id>
        </element-citation>
      </ref>
      <ref id="bib56">
        <element-citation publication-type="journal" id="sref56">
          <person-group person-group-type="author">
            <name>
              <surname>Yoo</surname>
              <given-names>M.-H.</given-names>
            </name>
            <name>
              <surname>Carlson</surname>
              <given-names>B.A.</given-names>
            </name>
            <name>
              <surname>Gladyshev</surname>
              <given-names>V.N.</given-names>
            </name>
            <name>
              <surname>Hatfield</surname>
              <given-names>D.L.</given-names>
            </name>
          </person-group>
          <article-title>Abrogated thioredoxin system causes increased sensitivity to TNF-Î±-induced apoptosis via enrichment of p-ERK 1/2 in the nucleus</article-title>
          <source>PLoS ONE</source>
          <volume>8</volume>
          <year>2013</year>
          <fpage>e71427</fpage>
          <pub-id pub-id-type="pmid">24039713</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec id="app1">
      <title>Accession Numbers</title>
      <p>The accession numbers for the atomic coordinates and structure factors of the Brf2-TBP/U6-2, Brf2-TBP/TRNAU1, and Brf2-TBP/RPPH1 structures reported in this paper are Protein Data Bank: <ext-link ext-link-type="uri" xlink:href="pdb:4ROC" id="intref0010">4ROC</ext-link>, <ext-link ext-link-type="uri" xlink:href="pdb:4ROD" id="intref0015">4ROD</ext-link>, and <ext-link ext-link-type="uri" xlink:href="pdb:4ROE" id="intref0020">4ROE</ext-link>, respectively.</p>
    </sec>
    <sec id="app3" sec-type="supplementary-material">
      <title>Supplemental Information</title>
      <p>
        <supplementary-material content-type="local-data" id="mmc1">
          <caption>
            <title>Document S1. Supplemental Experimental Procedures and Tables S1 and S2</title>
          </caption>
          <media xlink:href="mmc1.pdf"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="mmc2">
          <caption>
            <title>Document S2. Article plus Supplemental Information</title>
          </caption>
          <media xlink:href="mmc2.pdf"/>
        </supplementary-material>
      </p>
    </sec>
    <ack id="ack0010">
      <title>Acknowledgments</title>
      <p>We thank N. Cronin at The Institute of Cancer Research (ICR) for help with the crystallization setup and data collection. We thank the staff at beamlines ID29 and ID23eh1 of the European Synchrotron Radiation Facility (France) and at beamlines I24 and IO3 of Diamond Light Source (UK) for help with data collection. We thank the laboratories of Chris Lord and Pascal Meier for help with siRNA and FACS analysis, Tracy Berg for help with qRT-PCR, and Fredrik Wallberg of the ICR Flow Cytometry Facility and Sarah Hanrahan of the Proteomics Core Facility. We thank Richard Maraia and Aneeshkumar Arimbasseri for critical reading of an early version of the manuscript and Sonja Christoph for support throughout the project. P.C., O.D., and N.H. were supported by the University of Lausanne and by Swiss National Science Foundation (SNSF) grant 31003A_132958. A.V. acknowledges the support of the Career Development Faculty Program of the ICR. Part of this work was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) new-investigator award (BB/K014390/1) to A.V.</p>
    </ack>
    <fn-group>
      <fn id="d32e373">
        <p>This is an open access article under the CC BY license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" id="ccintref0005">http://creativecommons.org/licenses/by/4.0/</ext-link>).</p>
      </fn>
      <fn id="app2" fn-type="supplementary-material">
        <p>Supplemental Information includes Supplemental Experimental Procedures, seven figures, and two tables and can be found with this article online at <ext-link ext-link-type="doi" xlink:href="10.1016/j.cell.2015.11.005" id="intref0025">http://dx.doi.org/10.1016/j.cell.2015.11.005</ext-link>.</p>
      </fn>
    </fn-group>
  </back>
  <floats-group>
    <fig id="fig1">
      <label>FigureÂ 1</label>
      <caption>
        <p>Structure of the Brf2-TBP/DNA Ternary Complex</p>
        <p>(A) Overview of the Brf2-TBP/U6 promoter structure. DNA template and non-template strands are in blue and cyan respectively. Dashed lines represent disordered regions or regions not present in the crystallization construct.</p>
        <p>(B) Schematic of Brf2 domain organization.</p>
        <p>See also <xref rid="figs1" ref-type="fig">Figures S1</xref>, <xref rid="figs2" ref-type="fig">S2</xref>, and <xref rid="figs7" ref-type="fig">S7</xref> and <xref rid="mmc1" ref-type="supplementary-material">Tables S1</xref> and <xref rid="mmc1" ref-type="supplementary-material">S2</xref>.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>FigureÂ 2</label>
      <caption>
        <p>Architecture of the Human Pol III PIC</p>
        <p>Model of a Pol III PIC (<xref rid="bib51" ref-type="bibr">Vannini and Cramer, 2012</xref>) generated using the Brf2-TBP/DNA complex reveals that the path of the downstream DNA points toward the Pol III-specific subunits C39 and C62, and resembles the path observed in yeast and human Pol II PIC (<xref rid="bib17" ref-type="bibr">He etÂ al., 2013</xref>, <xref rid="bib37" ref-type="bibr">MÃ¼hlbacher etÂ al., 2014</xref>).</p>
        <p>See also <xref rid="figs7" ref-type="fig">FigureÂ S7</xref>.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>FigureÂ 3</label>
      <caption>
        <p>Brf2/DNA Sequence-Specific Interactions</p>
        <p>(A) Close-up view of the TATA box (yellow), downstream flanking region and sequence-specific interactions with Brf2. DNA template and non-template strands are in blue and cyan respectively.</p>
        <p>(B) Substitutions at positionsÂ +3 andÂ +4 of the wild-type (circled in red) U6-2 promoter decrease binding of a R110A mutant, in particular when a T nucleobase is present at positionÂ +3 on the non-template strand (in cyan). R110A versus wild-type (WT) is the ratio between the percentage of binding of the mutant versus wild-type Brf2 proteins.</p>
        <p>(C) Close-up view of the TATA box (yellow), upstream flanking region and sequence-specific interactions with Brf2. DNA template and non-template strands are in blue and cyan respectively.</p>
        <p>(D) Substitutions at positions â3 and â4 of the wild-type (circled in red) U6-2 promoter reveal more efficient complex formation with a pyrimidine nucleobase and a C nucleobase at positions â3 and â4 of the template strand, respectively. (B and D) The intensity of the complex formed with TBP, U6-2 non mutated sequence and wild-type Brf2 (lane 1) was used as a reference for relative quantification. <sup>â</sup>Indicates samples that were quantified relative to a distinct wild-type sequence reference not shown on the figure. Representative gels of three independent experiments. The data shown are the mean values and SE of three independent experiments. In the insets, 10Â Î¼l of a typical binding reaction (25Â Î¼l total) with Brf2 wild-type or Brf2 mutants were loaded on a SDS-PAGE gel and stained with Coomassie-blue, confirming that equal amounts of protein of comparable quality were used for EMSA assays.</p>
        <p>See also <xref rid="figs2" ref-type="fig">Figures S2</xref> and <xref rid="figs7" ref-type="fig">S7</xref>.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="fig4">
      <label>FigureÂ 4</label>
      <caption>
        <p>The Brf2 Molecular Pin</p>
        <p>(A) The Brf2 TBP anchor domain but not the molecular pin is essential for Brf2-TBP interaction in absence of the DNA, as shown by a pull-down assay.</p>
        <p>(B) The Brf2 TBP anchor domain and the molecular pin are essential for the formation of a Brf2-TBP/DNA complex, as shown in an EMSA.</p>
        <p>(C) Close-up view of the Brf2 molecular pin at the interface between the Brf2 C-cyclin repeat, TBP, and the DNA.</p>
        <p>See also <xref rid="figs3" ref-type="fig">Figures S3</xref> and <xref rid="figs7" ref-type="fig">S7</xref>.</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
    <fig id="fig5">
      <label>FigureÂ 5</label>
      <caption>
        <p>Brf2 Redox Regulation</p>
        <p>(A) Close-up view of C361 at the ternary interface between the Brf2 C-cyclin repeat, TBP, and the upstream edge of the TATA box. Yellow dots represent the van der Waals radius of the sulfur atom.</p>
        <p>(B) Representative EMSA of Brf2-TBP/DNA complexes upon pre-incubation of Brf2 proteins with the alkylating agent iodoacetamide. The IC band was used for loading normalization. <sup>â</sup>Indicates addition of the reducing agent after the oxidative treatment during complex assembly.</p>
        <p>(C) Representative EMSA of Brf2-TBP/DNA complexes upon removal of reducing agent (DTT) and incubation over time. The IC band was used for loading normalization. <sup>â</sup>Indicates addition of the reducing agent after the oxidative treatment during complex assembly.</p>
        <p>(D) Representative EMSA of Brf2-TBP/DNA complexes upon pre-incubation of Brf2 proteins with H<sub>2</sub>O<sub>2</sub>. The IC band was used for loading normalization. <sup>â</sup>Indicates addition of the reducing agent after the oxidative treatment during complex assembly.</p>
        <p>(E) Representative EMSA of Brf2-TBP/DNA complexes upon pre-incubation of Brf2 proteins with gradients of oxidized/reduced glutathione (GSSG:GSH). The IC band was used for loading normalization. <sup>â</sup>Indicates addition of the reducing agent after the oxidative treatment during complex assembly.</p>
        <p>See also <xref rid="figs3" ref-type="fig">Figures S3</xref>, <xref rid="figs4" ref-type="fig">S4</xref>, and <xref rid="figs7" ref-type="fig">S7</xref>.</p>
      </caption>
      <graphic xlink:href="gr5"/>
    </fig>
    <fig id="fig6">
      <label>FigureÂ 6</label>
      <caption>
        <p>Brf2-Dependent Transcription Is Redox Regulated in Living Cells</p>
        <p>(A) qRT-PCR analysis shows that Brf2-dependent-transcripts (SeCys p-tRNA, RPPH1, RNA7SK, and U6 snRNA) are globally downregulated during oxidative stress, while a Brf1-dependent transcript (Leu p-tRNA) remains unchanged.</p>
        <p>(B) SeCys p-tRNA levels are strongly reduced in cells challenged with t-BHP relative to the unchallenged cells (as highlighted by gray and black lines, respectively) in a dose- and time-dependent manner, as measured by qRT-PCR.</p>
        <p>(C) SeCys p-tRNA levels rapidly recover upon removal of the exogenous oxidative stress inducer, as measured by qRT-PCR. Wash indicates replacement of media containing t-BHP with fresh media.</p>
        <p>(D) Effects of overexpression of Brf2 and Brf2 mutants (inset) on SeCys p-tRNA levels during oxidative stress, as measured by qRT-PCR.</p>
        <p>The numbers indicated on the histograms represent the percentage of reduction of selenocysteine tRNA levels, while if numbers are indicated above the histograms they represent the percentage of increase. Cumulative data of at least three experiments, meanÂ + SEM. Unpaired t test: <sup>â</sup>pÂ &lt; 0.05; <sup>ââ</sup>pÂ &lt; 0.005; <sup>âââ</sup>pÂ &lt;Â 0.0005; <sup>ââââ</sup>pÂ &lt; 0.0001. p &gt; 0.05 were deemed not significant and values were not reported.</p>
        <p>See also <xref rid="figs5" ref-type="fig">Figures S5</xref> and <xref rid="figs7" ref-type="fig">S7</xref>.</p>
      </caption>
      <graphic xlink:href="gr6"/>
    </fig>
    <fig id="fig7">
      <label>FigureÂ 7</label>
      <caption>
        <p>Selenoproteins Levels and Resistance to Oxidative Stress Are Regulated in a Brf2-Dependent Manner</p>
        <p>(A) Manipulation of Brf2 protein levels affects selenoproteins expression levels during oxidative stress in MRC5 and A549 cells. In the upper insets, a western blot analysis of Nrf2 confirms induction of oxidative stress with 50Â Î¼M and 100Â Î¼M t-BHP in MRC5 and A549 cells, respectively. A western blot analysis of Brf2 immunoprecipitation from 10<sup>7</sup> MRC5 or A549 cells is shown in the lower insets (IP).</p>
        <p>(B) Overexpression of Brf2 in MRC5 cells challenged with t-BHP results in decreased apoptosis as measured by FACS analysis via annexin V-FITC/PI staining. The y axis represents the % of apoptotic cells, including both cells in early (annexin V-positive and PI-negative) and late (annexin V-positive and PI-positive) apoptosis.</p>
        <p>(C) Effects of overexpression of Brf2 wild-type and mutants on acquired resistance to apoptosis in MRC5 cells as measured by FACS analysis via annexin V-FITC/PI staining. The y axis represents the % of apoptotic cells, including both cells in early (annexin V-positive and PI-negative) and late (annexin V-positive and PI-positive) apoptosis.</p>
        <p>(D) Lowering Brf2 protein levels by siRNA in A549 cells challenged with t-BHP results in an increased cellular commitment to apoptosis as measured by FACS analysis via annexin V-FITC/PI staining. Inset: a western blot analysis of Brf2 immunoprecipitation from 10<sup>7</sup> A549 cells shows siRNA-induced Brf2 protein level reduction. The y axis represents the % of apoptotic cells, including both cells in early (annexin V-positive and PI-negative) and late (annexin V-positive and PI-positive) apoptosis.</p>
        <p>See also <xref rid="figs5" ref-type="fig">Figures S5</xref> and <xref rid="figs7" ref-type="fig">S7</xref>.</p>
      </caption>
      <graphic xlink:href="gr7"/>
    </fig>
    <fig id="figs1">
      <label>FigureÂ S1</label>
      <caption>
        <p>General Conservation of the Architecture of TFIIB and TFIIB-like Factors, Related to <xref rid="fig1" ref-type="fig">FigureÂ 1</xref></p>
        <p>(A) Schematic of the architecture of the Brf2-TBP/DNA complexes and sequences of the DNA scaffold used for crystallization.</p>
        <p>(B) Superimposition of Brf2-TBP/DNA and TFIIB-TBP/DNA (PDB: <ext-link ext-link-type="uri" xlink:href="pdb:1C9B" id="intref0030">1C9B</ext-link>). The structures were superimposed using TBP as a template for structural alignment.</p>
        <p>(C) Superimposition of the Brf2-TBP/U6-2 (blue), Brf2-TBP/TRNAU1 (grey) and Brf2-TBP/RPPH1 (green) structures. The structures were superimposed using TBP as a template for structural alignment.</p>
        <p>(D) Final electron density contoured at 1.2Â s surrounding a tract of double-stranded DNA.</p>
        <p>(E) Brf2 sequence conservation and domain organization of Homo sapiens (H.s.) Mus musculus (M.m.), and Danio rerio (D.r.).</p>
      </caption>
      <graphic xlink:href="figs1"/>
    </fig>
    <fig id="figs2">
      <label>FigureÂ S2</label>
      <caption>
        <p>Sequence Alignments of Brf2 Promoters and Protein, Related to <xref rid="fig1" ref-type="fig">Figures 1</xref> and <xref rid="fig3" ref-type="fig">3</xref></p>
        <p>(A) Brf2-dependent promoters (40 nucleobase long centered around putative TATA boxes) were aligned using MEME (Bailey etÂ al., 2009) by searching for a 16 nucleobase long consensus motif.</p>
        <p>(B) Sequence and domain conservation between Brf2, Brf1 and TFIIB. Color-coding is as in Fig.Â 1. Brf2-Brf1 alignments are based on sequence conservation, while Brf2-TFIIB is based on a structural alignment.</p>
        <p>(C) Two views of the specific interaction of Brf2 R110 and A108 with a TG (U6-2 in pale green) and TC (RPPH1 in light grey) dinucleotide step. In presence of the TG sequence, the T on the nontemplate strand (in red) is left unstacked at its downstream edge. In presence of a TC sequence, no local distortions of the DNA are observed. The two structures were superimposed by structurally aligning the Brf2 N-terminal cyclin repeats.</p>
      </caption>
      <graphic xlink:href="figs2"/>
    </fig>
    <fig id="figs3">
      <label>FigureÂ S3</label>
      <caption>
        <p>Modular Functions of the Brf2 CTD, Related to <xref rid="fig4" ref-type="fig">Figures 4</xref> and <xref rid="fig5" ref-type="fig">5</xref></p>
        <p>(A) EMSA with serial Brf2 C-terminal deletion mutants showing that the region comprised between residues 289-311 of Brf2 is involved in direct binding to the upstream transcription factor SNAPc.</p>
        <p>(B) A conserved surface of TBP is utilized by different TBP associated factors. The TBP surface buried upon interaction with the associated factor is colored in pink for human Brf2 (orange), in cyan for yeast Brf1 (PDB id: <ext-link ext-link-type="uri" xlink:href="pdb:1NGM" id="intref0035">1NGM</ext-link>, turquoise), in green for yeast TFIIA (PDB id: <ext-link ext-link-type="uri" xlink:href="pdb:1NH2" id="intref0040">1NH2</ext-link>, green) and in blue for yeast TAF1 (PDB id: <ext-link ext-link-type="uri" xlink:href="pdb:4B0A" id="intref0045">4B0A</ext-link>, blue).</p>
        <p>(C) Structural conservation between Brf2 C361 part of the molecular pin, and C59 part of a short helical motif of the p-50 subunit of the NF-kB transcription factor (PDB id: <ext-link ext-link-type="uri" xlink:href="pdb:1NFK" id="intref0050">1NFK</ext-link>).</p>
        <p>(D) Brf2 oxidative-mimic mutation C361D does not hinder Brf2-TBP complex formation in absence of the DNA, as shown by pull-down assay. âINâ indicates the input and âempty resinâ the eluted untagged TBP binding non-specifically to the resin.</p>
        <p>(E) EMSA shows that formation a functional Brf2-TBP/DNA complex is severely impaired in Brf2 oxidative-mimic mutant C361D. âINâ indicates the input and âempty resinâ the eluted untagged TBP binding non-specifically to the resin.</p>
        <p>(F) Fluorescence polarization saturation binding assay shows virtually no reduction in affinity of the Brf2 C361A mutant and an approximately 50-fold reduction in affinity of Brf2 C361D mutant for TBP/DNA complexes.</p>
      </caption>
      <graphic xlink:href="figs3"/>
    </fig>
    <fig id="figs4">
      <label>FigureÂ S4</label>
      <caption>
        <p>Mass Spectrometry Analysis of Brf2 Redox Modifications, Related to <xref rid="fig5" ref-type="fig">FigureÂ 5</xref></p>
        <p>Biologically relevant oxidation states of C361 were confirmed by MS/MS as either unmodified, trapped with glutathione (-SS-Glu) or dimedone (Dmd). The precursor ions, errors and ion scores are indicated below the annotated fragmentation mass spectra. For clarity, only prominent fragment ions are marked.</p>
      </caption>
      <graphic xlink:href="figs4"/>
    </fig>
    <fig id="figs5">
      <label>FigureÂ S5</label>
      <caption>
        <p>Brf2 is a Redox Sensor in Living Cells, Related to <xref rid="fig6" ref-type="fig">Figures 6</xref> and <xref rid="fig7" ref-type="fig">7</xref></p>
        <p>(A) SeCys m-tRNA levels are reduced during oxidative stress in a Brf2-dependent manner, as monitored via four-leaf clover PCR (Honda etÂ al., 2015). Samples labeled empty vector and Brf2 represent transient over-expressions.</p>
        <p>(B) Overexpression of Brf2 in MCF10A cells challenged with t-BHP results in decreased apoptosis as measured by FACs analysis via Annexin V-FITC/PI staining.</p>
        <p>(C) Overexpression of Brf2 affects selenoproteins expression levels during oxidative stress in MCF10A cells.</p>
        <p>(D) Effects of overexpression of Brf2 and Brf2 mutants on acquired resistance to apoptosis in MCF10A cells as measured by FACs analysis via Annexin V-FITC/PI staining.</p>
      </caption>
      <graphic xlink:href="figs5"/>
    </fig>
    <fig id="figs6">
      <label>FigureÂ S6</label>
      <caption>
        <p>Brf2-Dependent Reduction of SeCys p-tRNA and Enhanced Apoptosis in A549 Cells, Related to <xref rid="fig7" ref-type="fig">FigureÂ 7</xref></p>
        <p>(A) Two individual Brf2 siRNAs cause a severe reduction of SeCys p-tRNA in A549 cells challenged with t-BHP, an effect that is fully rescued by concomitant overexpression of a siRNA resistant form of Brf2.</p>
        <p>(B) Two individual Brf2 siRNAs elicit a strong sensitization towards t-BHP in A549 cells, an effect that is fully rescued by concomitant overexpression of a siRNA resistant form of Brf2.</p>
      </caption>
      <graphic xlink:href="figs6"/>
    </fig>
    <fig id="figs7">
      <label>FigureÂ S7</label>
      <caption>
        <p>Mechanism of the Redox-Dependent Brf2 Blockade during Oxidative Stress and Carcinogenesis, Related to <xref rid="fig1" ref-type="fig">Figures 1</xref>, <xref rid="fig2" ref-type="fig">2</xref>, <xref rid="fig3" ref-type="fig">3</xref>, <xref rid="fig4" ref-type="fig">4</xref>, <xref rid="fig5" ref-type="fig">5</xref>, <xref rid="fig6" ref-type="fig">6</xref>, and <xref rid="fig7" ref-type="fig">7</xref></p>
        <p>During normal growth conditions (A) Brf2- and Nrf2-dependent transcripts are synthesized at basal levels. Upon moderate oxidative stress (B), Nrf2 is activated and Nrf2-dependent transcripts upregulated. Concomitantly, Brf2-dependent transcription, including SeCys tRNAs, is rapidly downregulated via redox-dependent modifications of Brf2. The pre-existing pool of SeCys tRNA is sufficient to sustain synthesis of selenoproteins. Upon prolonged oxidative stress (C), SeCys tRNA levels become limiting while, simultaneously, selenoproteinâs mRNAs continue to be highly upregulated by Nrf2. In this scenario, compromised synthesis of selenoproteins drives the cells into apoptosis. In cancer cells (D), the Nrf2 pathway is constitutively activated and contributes to the observed resistance of cancerous cells to higher than normal concentrations of reactive oxygen species. Under these circumstances, Brf2 overexpression is required to overcome the innate redoxdependent blockade, ensuring elevated synthesis of SeCys tRNAs and, ultimately, enabling cancer cells to evade apoptosis under prolonged oxidative stress.</p>
      </caption>
      <graphic xlink:href="figs7"/>
    </fig>
  </floats-group>
</article>

</metadata></record></GetRecord></OAI-PMH>